GLP-1 Market
LLY $1169.60 ▼ -1.6% NVO $38.18 ▼ -0.2% PFE $27.82 ▼ -0.6% VKTX $27.73 ▼ -2.8% KLRA $10.00 ▼ -5.0% GPCR $25.67 ▼ -3.8% RHHBY $53.29 ▼ -1.4%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Atorvastatin Calcium Trihydrate

Company
Daiichi Sankyo
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
71 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

71 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Atorvastatin Calcium Trihydrate and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03753555

    The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

    Not yet reported General Hospital of Shenyang Military Region 100 participants Est. completion 2027-11-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis, Cerebral
    View official trial listing →
  • Recruiting NCT NCT03770702

    Statins and ARBs on Rheumatoid Activity

    Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2026-12-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03819101

    Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 1210 participants Est. completion 2042-03 30 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT04147286

    Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

    Not yet reported, Not yet reported University of Cape Town 220 participants Est. completion 2027-09-30 1 site
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Recruiting NCT NCT04262206

    Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    Not yet reported Duke University 20000 participants Est. completion 2026-12-31 106 sites Stand-alone
    Cardiovascular disease Other conditions: Cognitive Impairment, Mild, Dementia
    View official trial listing →
  • Recruiting NCT NCT04347434

    Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI

    Not yet reported Penza State University 300 participants Est. completion 2027-12-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Myocardial Strain, Arterial Stiffness, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT04601116

    The MASTER Study (MAmmary Cancer STatin ER Positive Study)

    Not yet reported Aarhus University Hospital 3360 participants Est. completion 2035-01-01 1 site
    Other conditions: Breast Cancer Female, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Recruiting NCT NCT04735263

    Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

    Not yet reported Massachusetts Eye and Ear Infirmary 21 participants Est. completion 2028-01-01 1 site
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Recruiting NCT NCT04765137

    Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

    Not yet reported Johns Hopkins University 20 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT04847752

    Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

    Tongji Hospital 1000 participants Est. completion 2028-12-31 1 site
    Cardiovascular disease Other conditions: Large-Artery Atherosclerosis (Embolus/Thrombosis)
    View official trial listing →
  • Recruiting NCT NCT04915183

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

    Not yet reported National Institute on Deafness and Other Communication Disorders (NIDCD) 224 participants Est. completion 2030-08-31 5 sites Stand-alone
    Other conditions: Hearing Loss, Head and Neck Cancer
    View official trial listing →
  • Recruiting NCT NCT04968509

    Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis

    Not yet reported Beijing Anzhen Hospital 160 participants Est. completion 2028-01 1 site Stand-alone
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Recruiting NCT NCT05028829

    Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

    Not yet reported Raymond Chung 60 participants Est. completion 2031-03-01 2 sites Stand-alone
    Other conditions: Liver Fibroses, Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT05030818

    Cross-over Study of Coronary Risk Factors With a Polypill

    Not yet reported Fundación EPIC 88 participants Est. completion 2026-04-30 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05076019

    Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement

    Not yet reported Odense University Hospital 266 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Postoperative Atrial Fibrillation
    View official trial listing →
  • Recruiting NCT NCT05289063

    Vascular Endothelial Dysfunction in Sleep Apnea

    Not yet reported Columbia University 110 participants Est. completion 2027-02-28 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT05365438

    Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

    Not yet reported Seoul National University Bundang Hospital 105 participants Est. completion 2026-12-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemias, Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT05397405

    Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

    Not yet reported Nanjing First Hospital, Nanjing Medical University 180 participants Est. completion 2026-05-01 2 sites Stand-alone
    Other conditions: Intracranial Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT05404139

    Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

    Not yet reported University Health Network, Toronto 352 participants Est. completion 2031-02 2 sites Stand-alone
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05483010

    Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

    Not yet reported Washington University School of Medicine 16 participants Est. completion 2028-05-31 1 site Stand-alone
    Other conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT05559164

    Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

    Not yet reported Rutgers, The State University of New Jersey 60 participants Est. completion 2027-03-01 10 sites Stand-alone
    Other conditions: Cardiac Toxicity, Early-stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05641753

    Cholesterol Lowering and Residual Risk in Diabetes, Type 1

    Not yet reported NYU Langone Health 125 participants Est. completion 2027-07-31 4 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT05705804

    Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

    Not yet reported Yonsei University 250 participants Est. completion 2027-06-01 1 site
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT05796973

    Measuring Oncological Value of Exercise and Statin

    Not yet reported Tampere University Hospital 240 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Prostate Cancer, Breast Cancer, Kidney Cancer, Ovarian Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Metastatic Prostate Cancer, Metastatic Prostate Adenocarcinoma, Metastatic Ovarian Cancer, Metastatic Ovary Cancer
    View official trial listing →
  • Recruiting NCT NCT06102863

    Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

    Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site Stand-alone
    Other conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
    View official trial listing →
  • Recruiting NCT NCT06199921

    ATORvastatin in Pulmonary TUBerculosis

    Not yet reported Obafemi Awolowo University Teaching Hospital 440 participants Est. completion 2026-09-30 8 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis, Tuberculosis, Koch's Disease
    View official trial listing →
  • Recruiting NCT NCT06248671

    Prophylactic Treatment With Atorvastatin for Episodic Migraine.

    Not yet reported St. Olavs Hospital 450 participants Est. completion 2029-02-28 6 sites
    Other conditions: Episodic Migraine
    View official trial listing →
  • Recruiting NCT NCT06308952

    Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

    Not yet reported Duan Chuanzhi 354 participants Est. completion 2027-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Cerebrovascular Event, Stent Stenosis, Stent Thrombosis, Death, Brain, Endothelial Dysfunction
    View official trial listing →
  • Recruiting NCT NCT06312748

    Novel Approaches for Improving Vascular Function in Veterans With HFpEF

    Not yet reported VA Office of Research and Development 90 participants Est. completion 2030-09-30 1 site Stand-alone
    Heart failure Other conditions: Inflammation
    View official trial listing →
  • Recruiting NCT NCT06327451

    Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

    Not yet reported Tianjin Medical University General Hospital 50 participants Est. completion 2027-02-28 1 site Stand-alone
    Other conditions: Glioblastoma, IDH-wildtype
    View official trial listing →
  • Recruiting NCT NCT06336174

    Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

    Anhui Medical University 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event
    View official trial listing →
  • Recruiting NCT NCT06358313

    Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-05-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06360120

    Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2025-10-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06485336

    Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

    Not yet reported St. Olavs Hospital 300 participants Est. completion 2029-02-28 6 sites
    Other conditions: Chronic Migraine
    View official trial listing →
  • Recruiting NCT NCT06501443

    LATAM LOWERS LDL-C

    Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Recruiting NCT NCT06604117

    Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

    Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 site
    Cardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, Statin
    View official trial listing →
  • Recruiting NCT NCT06632379

    AtorvaStatin Postpartum and Reduction of Cardiovascular risK

    Not yet reported Ohio State University 76 participants Est. completion 2026-12-15 1 site
    Other conditions: Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension
    View official trial listing →
  • Recruiting NCT NCT06690164

    Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

    Not yet reported National University Hospital, Singapore 78 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metabolite
    View official trial listing →
  • Recruiting NCT NCT06750783

    The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

    Not yet reported Beijing Tsinghua Chang Gung Hospital 398 participants Est. completion 2026-03-31 3 sites Stand-alone
    Other conditions: Prediabetic State (IGT)
    View official trial listing →
  • Recruiting NCT NCT06764966

    Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis

    Not yet reported CAMC Health System 50 participants Est. completion 2027-03 1 site
    Other conditions: Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver, Decompensated Cirrhosis and Ascites
    View official trial listing →
  • Recruiting NCT NCT06765265

    Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

    Not yet reported King Edward Medical University 152 participants Est. completion 2026-01-01 1 site
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Recruiting NCT NCT06784557

    Effect of Ezetimibe on Gut Microbiota

    Not yet reported Yonsei University 110 participants Est. completion 2025-10-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06785740

    Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 300 participants Est. completion 2029-09 4 sites
    Cardiovascular disease Other conditions: TIA
    View official trial listing →
  • Recruiting NCT NCT06858332

    Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

    Novartis Pharmaceuticals 2382 participants Est. completion 2027-09-30 20 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06896708

    Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome

    Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-alone
    Other conditions: Chronic Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06902740

    PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

    Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2028-12-31 19 sites Stand-alone
    Other conditions: Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic Plaque
    View official trial listing →
  • Recruiting NCT NCT06922994

    Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

    Not yet reported Centro Cardiologico Monzino 102 participants Est. completion 2026-11-30 5 sites
    Other conditions: Arrhythmogenic Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT06930885

    Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

    Not yet reported Hospital do Coracao 7713 participants Est. completion 2031-05 13 sites Stand-alone
    Cardiovascular disease Other conditions: Atherothrombotic Diseases
    View official trial listing →
  • Recruiting NCT NCT06961630

    Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

    Not yet reported NYU Langone Health 50 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: Myocardial Injury After Noncardiac Surgery
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT07012629

    A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

    Not yet reported Aarhus University Hospital 1652 participants Est. completion 2040-01-01 14 sites Stand-alone
    Other conditions: Covert Brain Infarction
    View official trial listing →
  • Recruiting NCT NCT07036991

    A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis

    Changhai Hospital 406 participants Est. completion 2027-06-01 1 site
    Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT07045142

    Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

    Not yet reported Central South University 400 participants Est. completion 2028-06-01 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07083206

    A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

    Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07088250

    Statins for Treatment of Primary Intracerebral Hemorrhage

    Not yet reported The Second Hospital of Anhui Medical University 264 participants Est. completion 2026-12-31 22 sites Stand-alone
    Other conditions: Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral Haemorrhage
    View official trial listing →
  • Recruiting NCT NCT07265466

    to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

    Not yet reported Onconic Therapeutics Inc. 96 participants Est. completion 2026-03-30 1 site Stand-alone
    Other conditions: Drug Drug Interaction (DDI)
    View official trial listing →
  • Recruiting NCT NCT07303699

    ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

    Not yet reported Obafemi Awolowo University Teaching Hospital 80 participants Est. completion 2028-03-30 3 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis (TB)
    View official trial listing →
  • Recruiting NCT NCT07307989

    Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

    Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2029-07-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypercholesteremia
    View official trial listing →
  • Recruiting NCT NCT07344610

    Effects of Short-term Intensive Statin Therapy on Lipid Levels

    General Hospital of Shenyang Military Region 800 participants Est. completion 2026-12-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07359105

    Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

    Not yet reported Sin Gon Kim 2186 participants Est. completion 2029-12-31 2 sites Stand-alone
    Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07400757

    Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

    Not yet reported Taipei Veterans General Hospital, Taiwan 120 participants Est. completion 2032-07-15 1 site Stand-alone
    Other conditions: Thyroid Eye Disease, TED, Graves Ophthalmopathy
    View official trial listing →
  • Recruiting NCT NCT07524101

    Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

    Not yet reported Yonsei University 1952 participants Est. completion 2031-01-22 1 site Stand-alone
    Cardiovascular disease Other conditions: Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Recruiting NCT NCT07530640

    Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities

    Not yet reported Children's Hospital of Fudan University 9 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Kawasaki Disease, Coronary Artery Abnormalities
    View official trial listing →
  • Recruiting NCT NCT07554820

    Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

    Not yet reported Shaikh Zayed Hospital, Lahore 120 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Major Adverse Cardiac Events
    View official trial listing →
  • Recruiting NCT NCT07611747

    Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

    Not yet reported Instituto de Investigación Marqués de Valdecilla 1944 participants Est. completion 2031-12 17 sites Stand-alone
    Other conditions: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular Disease, Atherosclerosis, Carotid Artery Diseases
    View official trial listing →
  • Recruiting NCT NCT07680595

    Prospective Management of Plaque Instability With Statins and Extra Folic Acid

    Not yet reported, Not yet reported Ruijin Hospital 180 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Carotid Atherosclerotic Plaque
    View official trial listing →
  • Recruiting NCT NCT07685938

    Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07704918

    Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Melanoma
    View official trial listing →
  • Recruiting NCT NCT07727681

    Perioperative Statins to Prevent AFib After Lung Surgery

    Not yet reported Peking Union Medical College Hospital 540 participants Est. completion 2028-01-02 2 sites Stand-alone
    Other conditions: Postoperative Atrial Fibrillation, Lung Surgery
    View official trial listing →
  • Recruiting NCT NCT07785934

    Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

    Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 48 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Drug Drug Interaction (DDI), Pharmacokinetics and Pharmacodynamics
    View official trial listing →
  • Recruiting NCT NCT07824323

    Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome

    Not yet reported Taipei Medical University Hospital 400 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00000941

    A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants Est. completion 2002-03 13 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00004466

    Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5 participants Est. completion 1999-12 1 site Stand-alone
    Other conditions: Nephrotic Syndrome, Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT00004564

    The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: Hypercholesterolemia, Thrombosis
    View official trial listing →
  • Completed NCT NCT00017758

    The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants 10 sites
    Other conditions: HIV Infections, HIV Seronegativity, Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00023231

    Pediatric Kidney Transplant Without Calcineurin Inhibitors

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2006-08 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00024531

    Lipitor as a Treatment for Alzheimer's Disease

    Not yet reported Institute for the Study of Aging (ISOA) 98 participants Est. completion 2004-08 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00065806

    Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)

    Not yet reported Laura Schanberg 221 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00072826

    Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease

    Not yet reported National Institutes of Health Clinical Center (CC) 44 participants Est. completion 2007-08-24 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00079638

    Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

    Not yet reported Kos Pharmaceuticals 300 participants Est. completion 2005-05
    Cardiovascular disease Other conditions: Dyslipidemia, Coronary Heart Disease, Atherosclerosis, Diabetes
    View official trial listing →
  • Completed NCT NCT00081731

    Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions

    Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 site
    Cardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery Obstruction
    View official trial listing →
  • Completed NCT NCT00090168

    Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

    Not yet reported Organon and Co 435 participants Est. completion 2004-11-10
    Other conditions: Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092625

    Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

    Not yet reported Organon and Co 442 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092638

    An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

    Not yet reported Organon and Co 450 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092690

    MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)

    Not yet reported Organon and Co 1902 participants Est. completion 2004-03
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092716

    Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

    Not yet reported Organon and Co 655 participants Est. completion 2003-04
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00094172

    Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 82 participants Est. completion 2009-05 14 sites Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00103974

    Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

    Not yet reported Bayhill Therapeutics 30 participants Est. completion 2007-03 4 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00110435

    A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)

    Not yet reported Organon and Co 1229 participants Est. completion 2005-12
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00115817

    The Effects of Atorvastatin in Patients With Atherosclerosis

    Not yet reported Brigham and Women's Hospital 36 participants Est. completion 2007-03 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00115830

    Rho Kinase in Patients With Atherosclerosis

    Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2007-02 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00120055

    Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

    Not yet reported University of Oslo School of Pharmacy Est. completion 2005-04
    Other conditions: Myopathy
    View official trial listing →
  • Completed NCT NCT00120133

    Atorvastatin (Lipitor) to Prevent Bone Pain

    Not yet reported Children's Mercy Hospital Kansas City 12 participants Est. completion 2007-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00120887

    Lupus Atherosclerosis Prevention Study

    Not yet reported Johns Hopkins University 200 participants Est. completion 2005-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00124397

    Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)

    Not yet reported University of Southern Denmark 186 participants Est. completion 2004-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00126048

    Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma

    Not yet reported, Not yet reported University of Glasgow 54 participants Est. completion 2007-09 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00127218

    High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly

    Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Withdrawn NCT NCT00127335

    Is Myopathy Part of Statin Therapy (IMPOSTER-16)

    Not yet reported Scripps Health Est. completion 2008-05 1 site
    Other conditions: Myopathic Conditions
    View official trial listing →
  • Completed NCT NCT00130481

    Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

    Not yet reported University of Florida 100 participants Est. completion 2007-04 1 site
    Type 2 diabetes Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00132717

    A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

    Not yet reported Organon and Co 450 participants Est. completion 2007-06-01
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00133380

    A Study in People With High Cholesterol

    Not yet reported Eli Lilly and Company 300 participants Est. completion 2006-09 28 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00134173

    A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

    Not yet reported Pfizer 1100 participants Est. completion 2006-09 146 sites
    Other conditions: Coronary Disease, Coronary Arteriosclerosis, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00134238

    Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.

    Not yet reported Pfizer 755 participants Est. completion 2006-12 51 sites
    Other conditions: Mixed Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00134264

    A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

    Not yet reported Pfizer 15067 participants Est. completion 2007-06 221 sites
    Other conditions: Coronary Disease, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00134485

    Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

    Not yet reported Pfizer 400 participants Est. completion 2006-03 41 sites
    Other conditions: Hypercholesterolemia, Familial, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00134498

    A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

    Not yet reported Pfizer 160 participants Est. completion 2006-11 44 sites
    Other conditions: Hypertriglyceridemia, Hyperlipoproteinemia Type IV
    View official trial listing →
  • Completed NCT NCT00134511

    Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

    Not yet reported Pfizer 30 participants Est. completion 2005-11 6 sites
    Other conditions: Hypercholesterolemia, Familial
    View official trial listing →
  • Completed NCT NCT00134550

    Improving Diabetic Foot Ulcers With Atorvastatin

    Not yet reported Asker & Baerum Hospital 13 participants Est. completion 2007-03 2 sites
    Other conditions: Foot Ulcer, Diabetes
    View official trial listing →
  • Completed NCT NCT00136942

    A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 370 participants 20 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00136981

    Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

    Not yet reported Pfizer 800 participants Est. completion 2006-11 34 sites
    Other conditions: Hypercholesterolemia, Familial, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00137176

    EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

    Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2008-10 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00137462

    Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

    Not yet reported Pfizer 900 participants Est. completion 2006-09 59 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00138762

    A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

    Not yet reported Pfizer 3800 participants Est. completion 2006-08 154 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00139061

    Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

    Not yet reported Pfizer 128 participants Est. completion 2006-05 26 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00141141

    Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 383 participants Est. completion 2007-04 35 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00141232

    Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 810 participants Est. completion 2006-07 59 sites
    Other conditions: Diabetes, Type 2
    View official trial listing →
  • Completed NCT NCT00143234

    Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1825 participants Est. completion 2005-07 118 sites
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00143676

    Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

    Not yet reported Takeda 448 participants Est. completion 2006-08 78 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00143741

    Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

    Not yet reported University of Chicago 20 participants Est. completion 2011-07 1 site
    Other conditions: End-Stage Kidney Disease
    View official trial listing →
  • Terminated NCT NCT00145431

    Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

    Not yet reported Pfizer 41 participants Est. completion 2006-12 27 sites
    Other conditions: Hyperlipoproteinemia Type III
    View official trial listing →
  • Completed NCT NCT00147602

    Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke

    Not yet reported Pfizer 4732 participants Est. completion 2005-11 130 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00150371

    Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1100 participants Est. completion 2005-05 84 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00150384

    Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2005-08 106 sites
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00150722

    High-Density Lipoprotein (HDL) Modulation and Endothelial Function

    Not yet reported University of Calgary 75 participants Est. completion 2008-08 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00150943

    Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis

    Not yet reported UMC Utrecht 140 participants 1 site
    Other conditions: Renal Artery Obstruction, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00151502

    To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600 participants Est. completion 2007-07 99 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00153166

    ARREST PAD (Peripheral Arterial Disease)

    Not yet reported, Not yet reported Brigham and Women's Hospital 76 participants Est. completion 2011-12 1 site Stand-alone
    Alcohol use disorder Other conditions: Arterial Occlusive Disease, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00154024

    Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

    Not yet reported Technische Universität Dresden Est. completion 2006-10 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00157924

    Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

    Not yet reported Organon and Co 190 participants Est. completion 2007-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00159718

    Double Blind Atorvastatin Amlodipine Study

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 360 participants Est. completion 2007-01 33 sites
    Other conditions: Angina
    View official trial listing →
  • Completed NCT NCT00159835

    Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD

    Not yet reported Pfizer 8600 participants Est. completion 2005-03 194 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00163150

    Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 128 participants Est. completion 2006-02 1 site
    Other conditions: Cerebrovascular Accident, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00163163

    Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 400 participants Est. completion 2006-07 69 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00163202

    Comparative Atorvastatin Pleiotropic Effects

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2005-08 74 sites
    Other conditions: Coronary Arteriosclerosis, Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00164086

    Atorvastatin in Myeloma

    Not yet reported Bayside Health 1 site
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT00166036

    Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells

    Not yet reported Emory University 36 participants Est. completion 2009-04 1 site Stand-alone
    Metabolic syndrome Other conditions: Diabetes Mellitus, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00166504

    Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)

    Not yet reported Organon and Co 203 participants Est. completion 2007-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00166530

    EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)

    Not yet reported Organon and Co 367 participants Est. completion 2007-02
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00172419

    The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.

    Not yet reported National Taiwan University Hospital 43 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00174304

    Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1120 participants Est. completion 2006-09 102 sites
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00174330

    Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2006-02 15 sites
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00181181

    The Effect of Statin Use on Vascular Function in Hypertensive Subjects

    Not yet reported Johns Hopkins University 24 participants Est. completion 2007-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185731

    Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

    Not yet reported Dean Felsher 25 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00194402

    SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

    Not yet reported University of Washington 64 participants Est. completion 2006-01 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00195793

    A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

    Not yet reported Abbott 174 participants
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00199745

    Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

    Not yet reported Oslo University Hospital 53 participants Est. completion 2008-12 1 site
    Other conditions: Muscular Diseases
    View official trial listing →
  • Status unknown NCT NCT00201552

    Statin and PAF in Patients With Pacemaker

    Not yet reported National Taiwan University Hospital 1 site
    Other conditions: Paroxysmal Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00202904

    Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

    Not yet reported Organon and Co 81 participants Est. completion 2006-10 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00211939

    CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

    Not yet reported Nabi Biopharmaceuticals 203 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Calcinosis, Arteriosclerosis, Hyperparathyroidism, Secondary
    View official trial listing →
  • Completed NCT NCT00214630

    LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

    Not yet reported AstraZeneca 825 participants Est. completion 2007-08 56 sites
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT00231803

    The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

    Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00233480

    Statin Therapy in Heart Failure: Potential Mechanisms of Benefit

    Not yet reported University of California, Los Angeles 27 participants Est. completion 2009-02 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00235950

    Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

    Not yet reported AstraZeneca 255 participants Est. completion 2006-03 18 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00239330

    Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

    Not yet reported AstraZeneca 824 participants Est. completion 2005-02 26 sites
    Other conditions: Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT00241488

    DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

    Not yet reported AstraZeneca 1362 participants Est. completion 2007-02 34 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00242944

    Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

    Not yet reported Kyoto University 307 participants Est. completion 2008-03 3 sites
    Other conditions: Coronary Disease, Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT00243672

    Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques

    Not yet reported University Hospital Muenster 100 participants Est. completion 2007-10
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00249249

    Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

    Not yet reported Kowa Research Europe 830 participants Est. completion 2006-11 192 sites
    Other conditions: Primary Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT00249899

    Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia

    Not yet reported Takeda 649 participants Est. completion 2007-03 23 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00251680

    Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

    Not yet reported Takeda 400 participants Est. completion 2007-05 77 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00252967

    Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)

    Not yet reported Emory University 64 participants Est. completion 2009-10 3 sites Stand-alone
    Other conditions: Atrial Fibrillation, Inflammation
    View official trial listing →
  • Completed NCT NCT00259662

    High-dose Periop Statins for Prevention of DVT

    Not yet reported Yale University 29 participants Est. completion 2007-08 1 site
    Other conditions: Gynecologic Oncological Pelvic/Abdominal Surgery
    View official trial listing →
  • Completed NCT NCT00267254

    A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

    Not yet reported Pfizer 640 participants Est. completion 2006-08 49 sites
    Other conditions: Hyperlipidemia, Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00267267

    A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

    Not yet reported Pfizer 1784 participants Est. completion 2007-01 123 sites
    Other conditions: Hyperlipidemia, Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT00267280

    A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

    Not yet reported Pfizer 640 participants Est. completion 2006-12 51 sites
    Other conditions: Hyperlipidemia, Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00276133

    Effects of Atorvastatin Versus Probucol on Small Dense LDL

    Not yet reported Yokohama City University Medical Center 24 participants Est. completion 2007-05 1 site
    Other conditions: Chronic Nephropathy
    View official trial listing →
  • Completed NCT NCT00276458

    To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

    Not yet reported Organon and Co 196 participants Est. completion 2008-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00276484

    To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

    Not yet reported Organon and Co 579 participants Est. completion 2008-03 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00279708

    Atorvastatin to Treat Pulmonary Sarcoidosis

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 55 participants Est. completion 2015-12 1 site
    Other conditions: Sarcoidosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT00286312

    Myocardial Infarction Size Reduction With Atorvastatin

    Not yet reported R&D Cardiologie 50 participants Est. completion 2008-02 2 sites
    Cardiovascular disease Other conditions: Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT00289900

    Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

    Not yet reported Merck Sharp & Dohme LLC 2340 participants Est. completion 2010-08-06
    Other conditions: Mixed Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00292201

    Statin Treatment in Patients With Asthma

    Not yet reported Queen's University 10 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00293748

    Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease

    National Institute of Neurological Disorders and Stroke (NINDS) 200 participants Est. completion 2008-12-15 1 site
    Other conditions: Vascular Disease, Vascular Disease Risk
    View official trial listing →
  • Completed NCT NCT00296374

    Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

    Not yet reported AstraZeneca 353 participants Est. completion 2009-03 116 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00296387

    Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

    Not yet reported AstraZeneca 1160 participants Est. completion 2007-10 102 sites
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00296400

    Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease

    Not yet reported AstraZeneca 237 participants Est. completion 2009-06 107 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00297973

    Cardiovascular Risk Assessment in Patients Treated With Caduet

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1442 participants Est. completion 2007-04 384 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00299884

    Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

    Queen's University 45 participants Est. completion 2006-07 1 site
    Other conditions: Dyslipidemia, Vascular Disease
    View official trial listing →
  • Completed NCT NCT00300430

    Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

    Not yet reported Abbott 1911 participants 1 site
    Other conditions: Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00300469

    Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

    Not yet reported Abbott 613 participants 1 site
    Other conditions: Mixed Dyslipidemia, Coronary Heart Disease, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00303277

    Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

    Not yet reported Seattle Institute for Biomedical and Clinical Research 35 participants Est. completion 2005-04 1 site
    Other conditions: Alzheimer's Disease, Aging
    View official trial listing →
  • Completed NCT NCT00309751

    Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

    Not yet reported Kowa Research Europe 418 participants Est. completion 2007-06 35 sites
    Other conditions: Type II Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00317967

    Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart

    Not yet reported University of Calgary 22 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT00319449

    Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

    Not yet reported Organon and Co 22 participants Est. completion 2006-10 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00327418

    CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

    Not yet reported Pfizer 2800 participants Est. completion 2004-02 135 sites
    Other conditions: Major Coronary Event, Cerebrovascular Accident, Coronary Artery Bypass Graft, Angina, Unstable, Revascularization
    View official trial listing →
  • Completed NCT NCT00327691

    A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

    Not yet reported Pfizer 8600 participants Est. completion 2004-08 314 sites
    Cardiovascular disease Other conditions: Cerebrovascular Accident, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00329069

    The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

    Not yet reported University of Ulm 50 participants Est. completion 2006-03 1 site
    Cardiovascular disease Other conditions: Hypercholesterolemia, Monocyte Function
    View official trial listing →
  • Completed NCT NCT00329173

    PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

    Not yet reported AstraZeneca 1000 participants Est. completion 2004-08
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00330785

    Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1250 participants Est. completion 2005-09 126 sites
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00331565

    Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin

    Not yet reported University of Oslo School of Pharmacy 36 participants Est. completion 2010-12 1 site
    Other conditions: Morbid Obesity
    View official trial listing →
  • Completed NCT NCT00332761

    Caduet in an Untreated Subject Population

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sites
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00335504

    Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

    Not yet reported National Cancer Institute (NCI) 85 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Colon Cancer, Precancerous Condition, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00335699

    Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome

    Not yet reported AstraZeneca 370 participants Est. completion 2007-01 7 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00343655

    Evaluation of Atorvastatin Treatment on Carotid Plaque.

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160 participants Est. completion 2007-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00344019

    Effects of Atorvastatin on Myonecrosis

    Not yet reported Beth Israel Deaconess Medical Center 97 participants Est. completion 2009-01 1 site
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00344370

    Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

    Not yet reported Kowa Research Europe 214 participants Est. completion 2008-04 35 sites
    Other conditions: Type II Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00344955

    Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

    Not yet reported Regional Hospital Holstebro 20 participants Est. completion 2003-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00345202

    Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

    Not yet reported Regional Hospital Holstebro 20 participants Est. completion 2005-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00355251

    Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

    Not yet reported Germans Trias i Pujol Hospital 5 participants Est. completion 2007-02 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00356473

    Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis

    Not yet reported University of California, Los Angeles 20 participants Est. completion 2005-09 Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00359281

    Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

    Not yet reported Aegerion Pharmaceuticals, Inc. 125 participants Est. completion 2007-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00361283

    Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

    Not yet reported University of Florida 108 participants Est. completion 2009-01 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT00362934

    Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

    Not yet reported Solvay Pharmaceuticals 516 participants Est. completion 2008-08 68 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00367458

    Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2008-06-19 3 sites Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT00368589

    Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging

    GlaxoSmithKline 47 participants Est. completion 2007-08 1 site
    Other conditions: Atherosclerotic Carotid Disease, Atheroma, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00375518

    Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery

    Not yet reported Memorial Sloan Kettering Cancer Center 162 participants Est. completion 2014-05 1 site
    Other conditions: Thoracic Surgery
    View official trial listing →
  • Completed NCT NCT00380939

    This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.

    Not yet reported Pfizer 600 participants Est. completion 2000-12 36 sites
    Other conditions: Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00382460

    Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

    Not yet reported Bristol-Myers Squibb 4000 participants Est. completion 2003-12
    Other conditions: Actue Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT00388596

    A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.

    Not yet reported GlaxoSmithKline 36 participants 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00392717

    Regulation of Lipoprotein Metabolism in Obese Men

    Not yet reported The University of Western Australia 48 participants Est. completion 2002-03 1 site
    Other conditions: Obesity, Dyslipidemia, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00395486

    ROMEO (Rosuvastatin in Metabolic syndrOme)

    Not yet reported AstraZeneca 258 participants Est. completion 2008-06 3 sites
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00395603

    Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

    Not yet reported Organon and Co 550 participants Est. completion 2007-06
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00396721

    Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

    Not yet reported Josep m Cruzado 23 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Glomerulonephritis, IGA, Nephropathy, IGA, IGA Nephropathy
    View official trial listing →
  • Completed NCT NCT00403533

    Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus

    Not yet reported Massachusetts General Hospital 10 participants Est. completion 2006-07 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT00404599

    Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.

    Not yet reported Amsterdam UMC, location VUmc 60 participants Est. completion 2009-07 1 site
    Other conditions: Diabetes Mellitus, Hypertension
    View official trial listing →
  • Completed NCT NCT00405717

    Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel

    Not yet reported Shenyang Northern Hospital 1300 participants Est. completion 2008-05 1 site
    Other conditions: Ischemic Heart Disease, Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT00407537

    Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1531 participants Est. completion 2009-10 125 sites Stand-alone
    Other conditions: Hypertension, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00408382

    Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

    Not yet reported Astellas Pharma Inc 50 participants 2 sites
    Cardiovascular disease Other conditions: Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT00409773

    Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)

    Not yet reported Organon and Co 1143 participants Est. completion 2008-07
    Metabolic syndrome Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00411190

    Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin

    Not yet reported GlaxoSmithKline 32 participants Est. completion 2006-12-15 2 sites Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT00412113

    A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 245 participants Est. completion 2008-04 51 sites Stand-alone
    Other conditions: Dyslipidemia, Hypertension
    View official trial listing →
  • Terminated NCT NCT00412841

    Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus

    Not yet reported NYU Langone Health 43 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Avascular Necrosis
    View official trial listing →
  • Completed NCT NCT00414531

    Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

    Not yet reported University of Oslo School of Pharmacy 53 participants Est. completion 2009-06 1 site
    Other conditions: Myotoxicity of Atorvastatin Treatment
    View official trial listing →
  • Completed NCT NCT00418834

    Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

    Not yet reported Organon and Co 1053 participants Est. completion 2008-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00427960

    Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

    Not yet reported AstraZeneca 55 participants Est. completion 2008-02 9 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Status unknown NCT NCT00432354

    An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

    Not yet reported, Not yet reported Buddhist Tzu Chi General Hospital 40 participants Est. completion 2009-03 2 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT00433823

    A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

    Not yet reported Abant Izzet Baysal University Est. completion 2008-01 1 site
    Other conditions: Coronary Heart Disease, Diabetes Mellitus, Non-Coronary Atherosclerotic Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00435045

    Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

    Not yet reported GlaxoSmithKline 245 participants Est. completion 2007-10 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Terminated NCT NCT00437892

    Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis

    Not yet reported Università degli Studi dell'Insubria 10 participants Est. completion 2011-05 3 sites Stand-alone
    Other conditions: Venous Thromboembolism, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00441597

    Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2009-03 1 site
    Cardiovascular disease Other conditions: Ischemia Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT00442325

    Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595 participants Est. completion 2004-02 32 sites
    Type 2 diabetes Other conditions: Coronary Arteriosclerosis, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT00442845

    Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2080 participants Est. completion 2004-02 121 sites
    Type 2 diabetes Other conditions: Coronary Arteriosclerosis, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT00442897

    Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

    Not yet reported Organon and Co 229 participants Est. completion 2008-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00446940

    Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

    Not yet reported Bader, Ted, M.D. 16 participants Est. completion 2007-03 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00449410

    Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients

    Not yet reported Radboud University Medical Center 35 participants Est. completion 2006-10 1 site
    Other conditions: Atrial Fibrillation, Neuropsychology, Magnetic Resonance Imaging, Inflammation, Hemostasis
    View official trial listing →
  • Status unknown NCT NCT00452608

    Statin for Immunomudulation in Sepsis

    Not yet reported Hospital de Clinicas de Porto Alegre 80 participants Est. completion 2009-12 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Terminated NCT NCT00452842

    Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

    Pfizer 26784 participants 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Disorders
    View official trial listing →
  • Completed NCT NCT00454545

    Atorvastatin in Moderate Active Crohns Disease

    Not yet reported Skane University Hospital 12 participants Est. completion 2007-10 1 site
    Other conditions: Crohns Disease
    View official trial listing →
  • Completed NCT NCT00457340

    Atorvastatin For The Reduction Of Ventricular Arrhythmias

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2004-09 10 sites
    Other conditions: Arrhythmia
    View official trial listing →
  • Completed NCT NCT00457405

    Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

    Not yet reported Radboud University Medical Center 10 participants Est. completion 2008-03 1 site
    Other conditions: Ischemia-Reperfusion Injury, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00458055

    High-Density Lipoprotein (HDL) Treatment Study

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 19 participants Est. completion 2007-09 1 site
    Other conditions: Coronary Arteriosclerosis, Hypoalphalipoproteinemias, Genetic Diseases, Inborn
    View official trial listing →
  • Completed NCT NCT00462748

    A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

    Not yet reported Organon and Co 786 participants Est. completion 2008-06
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00463827

    Effect of Statins on Asthma Control in Smokers With Asthma

    Not yet reported NHS Greater Clyde and Glasgow 71 participants Est. completion 2009-06 1 site
    Other conditions: Asthma, COPD, Smoking
    View official trial listing →
  • Completed NCT NCT00465088

    An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

    Not yet reported Abbott 199 participants 46 sites Stand-alone
    Other conditions: Hyperlipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00469326

    Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study

    Not yet reported University Hospital, Motol 200 participants Est. completion 2008-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00474240

    AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia

    Not yet reported Aegerion Pharmaceuticals, Inc. 157 participants Est. completion 2008-10 17 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00479388

    Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)

    Not yet reported Merck Sharp & Dohme LLC 1216 participants Est. completion 2008-10
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00481364

    Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients

    Not yet reported Ercan OK 446 participants Est. completion 2008-12 1 site
    Other conditions: Vascular Calcification, Atherosclerosis, Dyslipidemia, Inflammation
    View official trial listing →
  • Completed NCT NCT00487994

    Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

    Not yet reported Takeda 2130 participants Est. completion 2007-05 128 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00490698

    Zoledronate With Atorvastatin in Renal Cell Carcinoma

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Kidney Cancer, Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT00491400

    Effect of a Fibrate and a Statin on Endothelial Dysfunction

    Not yet reported Boston University 28 participants Est. completion 2008-12 1 site
    Metabolic syndrome Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00491530

    A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

    Not yet reported Abbott 310 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Mixed Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT00491751

    Clinical Utility of Endothelial Dysfunction in PAD

    Not yet reported Boston University 108 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00494247

    Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes

    Not yet reported Silesian School of Medicine 60 participants Est. completion 2009-08 2 sites
    Other conditions: Acute Coronary Syndromes, Coronary Heart Disease
    View official trial listing →
  • Terminated NCT NCT00494663

    A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

    Not yet reported DiObex 200 participants Est. completion 2008-12 24 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00496730

    A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)

    Not yet reported Organon and Co 256 participants Est. completion 2008-08
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00497016

    Does Statin Therapy Reduce Sympathoexcitation in Hypertension?

    Not yet reported Radboud University Medical Center 13 participants Est. completion 2008-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00504829

    Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

    Not yet reported Veloxis Pharmaceuticals 220 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00505336

    The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

    Not yet reported St Vincent's University Hospital, Ireland 43 participants Est. completion 2008-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT00517257

    Atorvastatin for the Treatment of Retinal Vein Occlusion

    Not yet reported University of Toronto 180 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Retinal Vein Occlusion, Retinal Vein Thrombosis, Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion, Thrombosis
    View official trial listing →
  • Completed NCT NCT00519363

    Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors

    Not yet reported, Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 15 participants Est. completion 2008-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT00520585

    Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes

    Not yet reported Masaryk University Est. completion 2007-11
    Other conditions: Heterogeneity of Cardiomyocytes Repolarisation, Autonomic Changes of Cardiomyocytes Repolarisation
    View official trial listing →
  • Completed NCT NCT00522158

    Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition

    Not yet reported Baskent University
    Type 2 diabetesCardiovascular disease Other conditions: LDL Cholesterol, Cognition
    View official trial listing →
  • Completed NCT NCT00529191

    Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Children's Hospital of Philadelphia 40 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00529542

    A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

    Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00530946

    A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 165 participants Est. completion 2008-04 17 sites
    Other conditions: Hypertension, Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00532311

    Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

    Not yet reported Takeda 411 participants Est. completion 2008-04 86 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00535405

    A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

    Not yet reported Organon and Co 1289 participants Est. completion 2009-03 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00536887

    Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction

    Not yet reported Korea University Anam Hospital 100 participants Est. completion 2008-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00540293

    Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 425 participants Est. completion 2008-05 20 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00541697

    Eze/Simva Switch Study in Diabetics (0653A-807)

    Not yet reported Organon and Co 648 participants Est. completion 2005-10-14
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00549926

    Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)

    Not yet reported Yokohama City University Medical Center 200 participants Est. completion 2010-02 1 site
    Other conditions: Coronary Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00559962

    Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

    Not yet reported Aegerion Pharmaceuticals, Inc. 260 participants Est. completion 2008-11 15 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00570752

    Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

    Not yet reported Bristol-Myers Squibb 72 participants Est. completion 2010-12 17 sites
    Other conditions: Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00572312

    Optimalization of Nephroprotection Using Atorvastatin (Sortis)

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00576576

    Evaluation of Atorvastatin on Atherosclerosis Composition

    Not yet reported Emory University 27 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00579098

    The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation

    Not yet reported Mayo Clinic 125 participants Est. completion 2011-12 1 site
    Other conditions: Atrial Fibrillation, Arrhythmia, Inflammation, Endothelial Dysfunction
    View official trial listing →
  • Terminated NCT NCT00579254

    Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112 participants Est. completion 2008-05
    Other conditions: Hypertension and Cardiovascular Risk Factors
    View official trial listing →
  • Terminated NCT NCT00585611

    Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients

    Not yet reported University of Wisconsin, Madison 1 participants Est. completion 2008-06 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT00587379

    Effect of Chronic Statin and Viagra Therapy in Persons With Endothelial Cell Dysfunction

    Not yet reported Mayo Clinic Est. completion 2008-05
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Terminated NCT NCT00590135

    The Effect of Lipitor on Aortic Stenosis

    Not yet reported The Cleveland Clinic 59 participants Est. completion 2010-04-26 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis
    View official trial listing →
  • Completed NCT NCT00603590

    Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

    Not yet reported Tehran University of Medical Sciences 475 participants Est. completion 2008-07 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension, Hyperlipidemia, Heart Disease
    View official trial listing →
  • Completed NCT NCT00609063

    The Effect of Statin Medications on Muscle Performance (The STOMP Study)

    Not yet reported Hartford Hospital 420 participants Est. completion 2011-06 3 sites Stand-alone
    Other conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases
    View official trial listing →
  • Completed NCT NCT00610545

    Atorvastatin in Perioperative Vascular Surgery - Pilot Study

    Not yet reported University of Campinas, Brazil 100 participants Est. completion 2008-12 1 site
    Other conditions: Vascular Surgery
    View official trial listing →
  • Completed NCT NCT00610870

    Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention

    Not yet reported Samsung Medical Center 173 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Angioplasty, Transluminal, Percutaneous Coronary
    View official trial listing →
  • Completed NCT NCT00611143

    Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery

    Not yet reported Samsung Medical Center 124 participants Est. completion 2007-05 1 site Stand-alone
    Other conditions: Coronary Artery Bypass
    View official trial listing →
  • Completed NCT NCT00615823

    Atorvastatin in Pulmonary Hypertension

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 220 participants Est. completion 2010-05 1 site
    Other conditions: Hypertension, Pulmonary
    View official trial listing →
  • Completed NCT NCT00616187

    Atorvastatin in Relapsing-Remitting Multiple Sclerosis

    Not yet reported Charite University, Berlin, Germany 41 participants
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00616772

    Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

    Not yet reported AbbVie (prior sponsor, Abbott) 682 participants Est. completion 2012-09 124 sites Stand-alone
    Cardiovascular disease Other conditions: Coronary Heart Disease, Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT00620204

    Efficacy Study of Atorvastatin to Treat Variant Angina

    Not yet reported Samsung Medical Center 136 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Angina Pectoris, Variant
    View official trial listing →
  • Completed NCT NCT00620542

    CRESTOR Athero Imaging Head to Head IVUS Study

    Not yet reported AstraZeneca 2333 participants Est. completion 2011-06 195 sites
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00622089

    Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

    Not yet reported, Not yet reported DiObex 150 participants Est. completion 2008-12 24 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00627575

    AED/Statin Interaction Study

    Not yet reported GlaxoSmithKline 119 participants Est. completion 2008-09-12 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT00631189

    Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients

    Not yet reported AstraZeneca 668 participants Est. completion 2008-10 170 sites
    Other conditions: Type IIa and IIb Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT00632840

    Pharmacological Regulation of Fat Transport in Metabolic Syndrome

    Not yet reported The University of Western Australia 11 participants Est. completion 2007-12
    Cardiovascular disease Other conditions: Obesity, Lipid Disorders, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00636766

    Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque

    Not yet reported Aristotle University Of Thessaloniki 300 participants Est. completion 2009-01 1 site Stand-alone
    Cardiovascular diseaseType 2 diabetesMetabolic syndrome Other conditions: Carotid Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00637481

    A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ
    View official trial listing →
  • Completed NCT NCT00639080

    Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients

    Endocrine Research Society 25 participants Est. completion 2010-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00639158

    Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

    Not yet reported Abbott 543 participants 118 sites
    Other conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT00640549

    Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 41 participants Est. completion 2004-10 14 sites
    Type 2 diabetes Other conditions: Hyperlipidemia, Non-Insulin Dependent Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00640744

    Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions

    Not yet reported Baylor College of Medicine 12 participants Est. completion 2010-02 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00644670

    A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232 participants Est. completion 2004-03 17 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00644709

    A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 196 participants Est. completion 2005-03 15 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00645151

    A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512 participants Est. completion 2005-02 33 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00645424

    A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 155 participants Est. completion 2004-10 5 sites Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT00647543

    Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 242 participants Est. completion 2004-04 4 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00650689

    Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

    Not yet reported Organon and Co 122 participants Est. completion 2004-12 Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00651378

    Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

    Not yet reported Organon and Co 87 participants Est. completion 2005-06-01 Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00651404

    Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

    Not yet reported Organon and Co 137 participants Est. completion 2004-12 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00652327

    Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

    Not yet reported Organon and Co 83 participants Est. completion 2007-07 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00653588

    Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

    Not yet reported AstraZeneca Est. completion 2004-09
    Other conditions: Hypercholesterolemia, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00653744

    Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

    Not yet reported AstraZeneca 1700 participants Est. completion 2004-03
    Other conditions: Hypercholesterolemia, Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00653796

    Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

    Not yet reported Organon and Co 148 participants Est. completion 2004-08-01 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653965

    Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

    Not yet reported AstraZeneca 3000 participants Est. completion 2005-02
    Other conditions: Hypercholesterolemia, Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00654095

    Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

    Not yet reported Organon and Co 146 participants Est. completion 2009-06-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654173

    Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)

    Not yet reported AstraZeneca 4444 participants Est. completion 2004-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654225

    Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

    Not yet reported AstraZeneca 2340 participants Est. completion 2005-03
    Other conditions: Hypercholesterolemia, Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00654407

    Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

    Not yet reported AstraZeneca 4875 participants Est. completion 2004-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654485

    COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

    Not yet reported AstraZeneca 940 participants Est. completion 2005-02
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00654537

    STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

    Not yet reported AstraZeneca 5625 participants Est. completion 2004-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT00656331

    The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

    Not yet reported University of New Mexico Est. completion 2012-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00663234

    IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia

    Not yet reported, Not yet reported International Maternal Pediatric Adolescent AIDS Clinical Trials Group 28 participants Est. completion 2014-12 11 sites Stand-alone
    Other conditions: HIV Infections, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00664469

    INdians Followed for INtensive Lipid Lowering Treatment and Its safetY

    Not yet reported Sunnybrook Health Sciences Centre 64 participants Est. completion 2010-11 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00664846

    Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

    Not yet reported Peking Union Medical College Hospital 4000 participants Est. completion 2011-04 46 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00664859

    12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

    Not yet reported, Not yet reported Veloxis Pharmaceuticals 140 participants Est. completion 2009-02 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00665834

    Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

    Not yet reported Queen's University 18 participants Est. completion 2007-09 2 sites
    Other conditions: Dyslipidemia, Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT00666029

    Implications for Treatment of the Metabolic Syndrome

    Not yet reported University Hospital Southampton NHS Foundation Trust 40 participants Est. completion 2008-02
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00669695

    Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin

    Not yet reported University Hospital, Grenoble 54 participants Est. completion 2013-02 4 sites
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00673660

    Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 375 participants Est. completion 2009-10 5 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT00675779

    Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis

    Not yet reported Poznan University of Medical Sciences 44 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Endometriosis, Pain
    View official trial listing →
  • Completed NCT NCT00678184

    The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake

    Not yet reported Regional Hospital Holstebro 23 participants Est. completion 2007-10 2 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00678522

    The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes

    Not yet reported Regional Hospital Holstebro 25 participants Est. completion 2008-05 2 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00681525

    A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

    Not yet reported Abbott 18 participants 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00683618

    Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

    Not yet reported AstraZeneca 934 participants Est. completion 2009-07 6 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00687076

    Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)

    Not yet reported Baylor College of Medicine 102 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00687271

    A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

    Not yet reported Merck Sharp & Dohme LLC 334 participants Est. completion 2009-01-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00689442

    Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

    Not yet reported Akros Pharma Inc. 105 participants Est. completion 2006-03 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00690443

    Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia

    Not yet reported Aegerion Pharmaceuticals, Inc. 44 participants Est. completion 2008-09 5 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00691314

    Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

    Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2010-12 10 sites Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Atherosclerosis, Stenosis, Stents
    View official trial listing →
  • Completed NCT NCT00700037

    Change in Plaque Characteristics With Atorvastatin

    Not yet reported Wakayama Medical University 70 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome, Atherosclerosis, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00701220

    Statin Therapy for Ischemic and Nonischemic Cardiomyopathy

    Not yet reported Philip Binkley 9 participants Est. completion 2010-12 1 site
    Cardiovascular disease Other conditions: Cardiomyopathy, Heart Disease, Myocardial Disease, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00701883

    Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol

    Not yet reported Gilead Sciences 183 participants Est. completion 2008-08 28 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00703261

    Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 83 participants Est. completion 2009-12
    Other conditions: Atherosclerotic Vascular Disease
    View official trial listing →
  • Completed NCT NCT00715273

    Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication

    Not yet reported University of Washington 217 participants Est. completion 2019-03-01 4 sites Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Diseases, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00716846

    Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers

    Not yet reported Hamamatsu University 11 participants Est. completion 2008-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00718796

    Naturopathic Treatment for the Prevention of Cardiovascular Disease

    Not yet reported The Canadian College of Naturopathic Medicine 300 participants Est. completion 2009-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00722956

    Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

    Not yet reported AstraZeneca 12 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Healthy Volunteers, Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT00723320

    Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis

    Not yet reported Ministry of Science and Technology of the People´s Republic of China 1200 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00728013

    China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome

    Not yet reported Ministry of Science and Technology of the People´s Republic of China 1600 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00728910

    Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study

    Not yet reported University of Pennsylvania 25 participants Est. completion 2009-08 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00728988

    Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 499 participants Est. completion 2010-04 26 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00730132

    Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)

    Organon and Co 712 participants Est. completion 2009-08
    Other conditions: Coronary Heart Disease, Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00734123

    Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

    Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00736463

    Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

    Not yet reported Oregon Health and Science University 80 participants 1 site
    Other conditions: HDL Cholesterol
    View official trial listing →
  • Completed NCT NCT00739999

    8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 39 participants Est. completion 2009-05 3 sites
    Other conditions: Pediatric Heterozygous Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00741078

    Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

    Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00741715

    Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia

    Not yet reported Sanofi 1736 participants Est. completion 2009-06 2 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00743925

    FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes

    Not yet reported Anthera Pharmaceuticals 625 participants Est. completion 2010-04 44 sites
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00745836

    Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients

    Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00751907

    Cerebral and Peripheral Perfusion Pilot Study

    Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00754507

    A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

    Not yet reported Daiichi Sankyo 65 participants Est. completion 2005-04 13 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00756886

    Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study

    Not yet reported University of Alabama at Birmingham 73 participants Est. completion 2011-05 1 site
    Other conditions: Arrhythmia
    View official trial listing →
  • Completed NCT NCT00758004

    Bioequivalence Study Of Pediatric Appropriate Formulation

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2009-03 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00760786

    Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

    Not yet reported Samsung Medical Center 60 participants 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT00767130

    DNA Diagnostic System for Statin Safety and Efficacy

    Genomas, Inc 750 participants Est. completion 2009-12 3 sites
    Other conditions: Hypercholesterolemia, Myopathy
    View official trial listing →
  • Terminated NCT NCT00767572

    Statins and Endothelial Function in Patients With Coarctation of the Aorta

    Not yet reported University of California, San Francisco 12 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Coarctation of the Aorta
    View official trial listing →
  • Completed NCT NCT00768638

    Study of Atorvastatin Dose Dependent Reduction of Proteinuria

    Not yet reported Laval University 23 participants Est. completion 2014-06 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00770575

    Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

    Not yet reported Takeda 148 participants Est. completion 2006-10 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00770679

    Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging

    Not yet reported Johns Hopkins University 16 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00770796

    Statins for Prevention of Contrast Induced Nephropathy

    Not yet reported Ospedale Misericordia e Dolce 304 participants Est. completion 2008-03
    Other conditions: Contrast Induced Nephropathy
    View official trial listing →
  • Completed NCT NCT00772564

    The Use of Statins for Myocardial Death Prevention

    Not yet reported Rambam Health Care Campus 25 participants Est. completion 2010-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00777517

    Bioequivalence Study On Pediatric Appropriate Formulation

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2009-02 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00782184

    Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

    Not yet reported Organon and Co 250 participants Est. completion 2010-09 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00791648

    Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery

    Not yet reported Vanderbilt University Medical Center 653 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Acute Kidney Injury, Post-Operative Delirium, Icu Delirium, Acute Renal Failure, Delirium
    View official trial listing →
  • Completed NCT NCT00793754

    Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People

    Not yet reported Fundacion GESICA 30 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00795912

    A Study Of The Usage Of Statins In A Community Heart Failure Population

    Not yet reported St Vincent's University Hospital, Ireland 56 participants Est. completion 2008-01 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00804843

    Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 100 participants Est. completion 2010-10 Stand-alone
    Other conditions: Carotid Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00805311

    Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

    Not yet reported Russian Cardiology Research and Production Center 400 participants Est. completion 2014-05 2 sites Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Stenosis, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00808717

    Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)

    Not yet reported Yonsei University 170 participants 1 site Stand-alone
    Cardiovascular disease Other conditions: Angioplasty, Percutaneous Coronary
    View official trial listing →
  • Status unknown NCT NCT00811330

    Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis

    Not yet reported University Hospital, Strasbourg, France 60 participants Est. completion 2018-01 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis, Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00814255

    Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

    Not yet reported NYU Langone Health 32 participants Est. completion 2014-02 18 sites
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00816244

    Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

    Not yet reported Lund University Hospital 50 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Breast Cancer, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT00818103

    Characteristic Study on Chinese Patients With Multiple Sclerosis

    Not yet reported Sun Yat-sen University 600 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00827606

    Atorvastatin Three Year Pediatric Study

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 272 participants Est. completion 2013-10 40 sites Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00844376

    Bioavailability Study for New Atorvastatin Formulation

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 12 participants Est. completion 2008-03 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00844402

    Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

    Not yet reported Medical University of Graz 40 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Primary Biliary Cirrhosis, Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00850460

    Quality of Life in Patients With Statin-Associated Myopathy

    Not yet reported Rockefeller University 14 participants Est. completion 2013-02 1 site
    Other conditions: Statin Adverse Reaction
    View official trial listing →
  • Completed NCT NCT00861861

    Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)

    Not yet reported Kumamoto University 129 participants Est. completion 2013-10 1 site
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00862251

    Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)

    Not yet reported Organon and Co 808 participants Est. completion 2011-03 Stand-alone
    Other conditions: Cardiovascular Disorder, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00864643

    Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia

    Not yet reported Takeda 172 participants Est. completion 2005-02 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00868127

    Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

    Not yet reported Takeda 574 participants Est. completion 2007-07 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00871351

    Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)

    Not yet reported Organon and Co 125 participants Est. completion 2010-05-01 Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00889226

    Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

    Not yet reported JW Pharmaceutical 161 participants Est. completion 2010-01
    Other conditions: Hypercholesterolemia With Type2DM
    View official trial listing →
  • Status unknown NCT NCT00902967

    Study To Check The Analgesic And Anti-Inflammatory Effects Of Atorvastatin In Patients Undergoing Abdominal Surgery

    Not yet reported B. J. Medical College, Pune 40 participants Est. completion 2010-02 1 site
    Other conditions: Abdominal Surgery
    View official trial listing →
  • Completed NCT NCT00910221

    Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial

    Not yet reported, Not yet reported Austin Health 100 participants Est. completion 2011-09 1 site
    Other conditions: Acute Kidney Dysfunction
    View official trial listing →
  • Terminated NCT NCT00911339

    Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 13 participants Est. completion 2021-05-13 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00914017

    Statins and Breast Cancer Biomarkers

    Not yet reported University of Vermont 100 participants 7 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00917527

    Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease

    Not yet reported Yonsei University 77 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00917579

    Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00917644

    Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00920101

    Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging

    Not yet reported National Defense Medical College, Japan 30 participants Est. completion 2013-12 1 site
    Other conditions: Atherosclerosis, Inflammation
    View official trial listing →
  • Completed NCT NCT00926614

    Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

    Not yet reported Brooke Army Medical Center 20 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Hepatitis c
    View official trial listing →
  • Completed NCT NCT00930670

    Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects

    Not yet reported Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 320 participants Est. completion 2011-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT00932048

    Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes

    Not yet reported Korea University Est. completion 2012-03 1 site Stand-alone
    Type 2 diabetes Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00942591

    Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

    Not yet reported Insel Gruppe AG, University Hospital Bern 77 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00944827

    Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia

    Not yet reported University of Thessaly 40 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00952770

    Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty

    Not yet reported Chungnam National University 140 participants 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00960323

    Drug-Drug Interaction Study Between Colchicine and Atorvastatin

    Not yet reported Mutual Pharmaceutical Company, Inc. 24 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00965055

    Ezetimibe in Patients Hypo-responsive to Statins

    Not yet reported University of California, San Diego 2 participants Est. completion 2012-09 1 site Stand-alone
    Cardiovascular disease Other conditions: High Cholesterol
    View official trial listing →
  • Completed NCT NCT00965185

    Statin Therapy to Improve Atherosclerosis in HIV Patients

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2014-01 1 site Stand-alone
    Cardiovascular disease Other conditions: HIV, Atherosclerosis, Inflammation, Statins, HMG-CoA, HIV Infections
    View official trial listing →
  • Completed NCT NCT00967252

    Impact of Chronic Statin Use During Surgery on Inflammation and Infection Rates

    Ottawa Hospital Research Institute 50 participants Est. completion 2011-07 1 site
    Other conditions: Inflammation, Infection, Endothelial Function
    View official trial listing →
  • Completed NCT NCT00967434

    Statin Drugs to Prevent Complications During Surgery

    Not yet reported Ottawa Hospital Research Institute 60 participants Est. completion 2010-12 1 site
    Cardiovascular disease Other conditions: Inflammation, Myocardial Ischemia
    View official trial listing →
  • Withdrawn NCT NCT00973271

    Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

    Not yet reported Essentialis, Inc. Est. completion 2011-12 Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00973986

    Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin

    Not yet reported Liuhuaqiao Hospital 20 participants Est. completion 2011-03 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Terminated NCT NCT00974740

    DIATOR-Diabetes Intervention With Atorvastatin

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 63 participants Est. completion 2009-03 12 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00977288

    A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

    Not yet reported Merck Sharp & Dohme LLC 408 participants Est. completion 2014-04 Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00979758

    Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 100 participants Est. completion 2016-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Stem Cell Transplantation, Angioplasty, Transluminal, Percutaneous Coronary
    View official trial listing →
  • Terminated NCT NCT00979940

    Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

    Not yet reported Indiana University 60 participants Est. completion 2014-08 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00986583

    Effect of Succinylcholine on Patients Using Statins

    Not yet reported The Cleveland Clinic 70 participants Est. completion 2010-07 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT00987974

    Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

    Not yet reported Radboud University Medical Center 48 participants Est. completion 2010-03 1 site
    Other conditions: Ischemia Reperfusion Injury, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00990808

    The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

    Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2011-07 Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00991705

    A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 28 participants Est. completion 2009-09
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00993915

    Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 687 participants Est. completion 2011-12
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01004406

    Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I

    Not yet reported VA Office of Research and Development 59 participants Est. completion 2013-03 2 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01013103

    Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

    Not yet reported Hippocration General Hospital 72 participants Est. completion 2012-02 1 site
    Cardiovascular disease Other conditions: HMG-CoA Reductase Inhibitor Toxicity, Atherosclerosis, Oxidative Stress, Endothelial Dysfunction
    View official trial listing →
  • Terminated NCT NCT01013870

    Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

    Not yet reported Baylor College of Medicine 52 participants Est. completion 2015-06 2 sites Stand-alone
    Other conditions: Traumatic Brain Injury, Post-traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT01015144

    The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle

    Medical University of Lodz Est. completion 2009-02
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01023607

    Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)

    Not yet reported Harbin Medical University 120 participants Est. completion 2013-08 1 site Stand-alone
    Cardiovascular disease Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01029522

    Dyslipidemia in Cardiovascular Disease

    Not yet reported Chong Kun Dang Pharmaceutical 244 participants Est. completion 2009-11 Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Withdrawn NCT NCT01030328

    AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

    Not yet reported Piedmont Healthcare Est. completion 2011-07 1 site
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT01033058

    Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

    Not yet reported Beijing Chao Yang Hospital 500 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: STEMI
    View official trial listing →
  • Status unknown NCT NCT01040936

    Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients

    Not yet reported Shanghai Jiao Tong University School of Medicine 300 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01041729

    Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease

    Not yet reported Hospital Universitario Getafe 60 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT01043380

    Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound

    Not yet reported Kumamoto University 245 participants Est. completion 2014-09 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01047501

    Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

    Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01047683

    Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

    Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01050348

    To Investigate the Role of Upstream High Dose Statin in STEMI

    Not yet reported The Western Pennsylvania Hospital 120 participants Est. completion 2010-06 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01053065

    The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study

    Not yet reported University of Padova 60 participants 3 sites
    Other conditions: Symptomatic Carotid Stenosis, Hypercholesterolemia, Indication for Carotid Endarterectomy
    View official trial listing →
  • Status unknown NCT NCT01058057

    Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2

    Not yet reported University Hospital, Motol 200 participants 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary Angioplasty
    View official trial listing →
  • Completed NCT NCT01059864

    Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

    Not yet reported Pfizer 111 participants Est. completion 2010-11 15 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01062802

    Statin Use in Abdominal Aortic Aneurysm Repair

    Not yet reported University of Hull 40 participants Est. completion 2008-12 1 site
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Status unknown NCT NCT01063426

    Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users

    Not yet reported Hallym University Medical Center 180 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Thrombosis, Prevention, Surgery
    View official trial listing →
  • Terminated NCT NCT01071993

    Efficacy of Statins In Prevention of CIN

    Not yet reported University of Oklahoma 21 participants Est. completion 2013-07 2 sites
    Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT01072097

    The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women

    Not yet reported University of Oulu 30 participants Est. completion 2011-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01073800

    Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill

    Not yet reported, Not yet reported University of Alberta 100 participants Est. completion 2011-09 1 site
    Cardiovascular disease Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT01078285

    Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2011-11 3 sites
    Other conditions: Medication Non-Adherence
    View official trial listing →
  • Completed NCT NCT01081548

    A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia

    Not yet reported Yonsei University 17 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01086020

    Atorvastatin Plus Ezetimibe on Coronary Plaque Progression

    Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2012-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01096875

    Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery

    Not yet reported Ankara University 60 participants Est. completion 2010-10 1 site
    Other conditions: Coronary Artery Bypass Surgery, Elective Surgical Procedure
    View official trial listing →
  • Completed NCT NCT01099176

    Effects of Hypolipemic Treatment on Adipokines

    Not yet reported Medical University of Silesia 78 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Hyperlipidemia, Impaired Fasting Glycemia
    View official trial listing →
  • Completed NCT NCT01105975

    A Study of LY2484595 in Patients With High LDL-C or Low HDL-C

    Not yet reported Eli Lilly and Company 398 participants Est. completion 2011-06 59 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01107743

    Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1291 participants Est. completion 2012-04
    Other conditions: Hypertension, Angina Pectoris, Hypercholesterolemia, Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01111656

    Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b

    Not yet reported Insel Gruppe AG, University Hospital Bern 28 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Relapsing-remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01112670

    The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology

    Not yet reported University of Colorado, Denver 33 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01115985

    A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Healthy, Pharmacokinetics of Atorvastatin
    View official trial listing →
  • Completed NCT NCT01126684

    Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion

    Not yet reported Aristotle University Of Thessaloniki 50 participants 1 site
    Other conditions: Hypertension, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01127945

    Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure Patients

    Not yet reported Yonsei University 50 participants Est. completion 2013-11 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT01130246

    VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome

    Not yet reported Anthera Pharmaceuticals 5189 participants Est. completion 2012-03 362 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01138072

    A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

    Not yet reported GlaxoSmithKline 14 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT01154036

    MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

    Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01161082

    Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin

    Not yet reported Regeneron Pharmaceuticals 72 participants Est. completion 2011-05 2 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01163851

    Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin

    Not yet reported Pfizer 25 participants Est. completion 2011-04 5 sites
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01166633

    Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

    Not yet reported JW Pharmaceutical 200 participants Est. completion 2011-02
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01175148

    Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

    Not yet reported West Virginia University 60 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT01185236

    Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

    Not yet reported Seoul National University Hospital 132 participants Est. completion 2011-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT01186289

    Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery

    Not yet reported Duke University Est. completion 2012-10 1 site Stand-alone
    Other conditions: Neurocognitive Dysfunction
    View official trial listing →
  • Terminated NCT NCT01187992

    Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease

    Not yet reported San Filippo Neri General Hospital 290 participants Est. completion 2007-04 1 site Stand-alone
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01190007

    Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 159 participants Est. completion 2012-02 20 sites
    Other conditions: Hypertension, Hypercholesterolemia, Angina Pectoris
    View official trial listing →
  • Completed NCT NCT01200056

    Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment

    Not yet reported Prof. Stephen Lee 40 participants Est. completion 2010-06 1 site
    Other conditions: Coronary Disease, Ultrasonography, Interventional, Hydroxymethylglutaryl-CoA Reductase Inhibitors
    View official trial listing →
  • Completed NCT NCT01208701

    The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy

    Not yet reported Erling Bjerregaard Pedersen 25 participants Est. completion 2012-01 1 site
    Cardiovascular disease Other conditions: Nephropathy, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01213498

    The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy

    Not yet reported Erling Bjerregaard Pedersen 25 participants Est. completion 2012-01 1 site
    Cardiovascular disease Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT01214746

    The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man

    Not yet reported Regional Hospital Holstebro 26 participants Est. completion 2011-06 1 site
    Cardiovascular disease Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT01218204

    A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

    Not yet reported GlaxoSmithKline 287 participants Est. completion 2011-06-29 21 sites Stand-alone
    Other conditions: Dyslipidaemias, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01220973

    Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

    Not yet reported Rutgers, The State University of New Jersey 27 participants Est. completion 2014-11-18 4 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01222182

    Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)

    Mayo Clinic 260 participants Est. completion 2011-06 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01223586

    Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome

    Kyoto University 238 participants Est. completion 2011-05 2 sites
    Other conditions: Statin, Coronary Plaque, Acute Coronary Syndrome, Intravascular Ultrasound, Cardiovascular Events
    View official trial listing →
  • Completed NCT NCT01228227

    ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading

    Not yet reported Gennaro Sardella 310 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Assess the Periprocedural Myocardial Necrosis
    View official trial listing →
  • Completed NCT NCT01236365

    Statins in Children With Type 1 Diabetes and Hypercholesterolemia

    Not yet reported Nemours Children's Clinic 42 participants Est. completion 2014-11 5 sites Stand-alone
    Other conditions: Diabetes Mellitus, Insulin-Dependent, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01236430

    A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

    Not yet reported Organon and Co 200 participants Est. completion 2012-02 Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT01239849

    Korean AMADEUS Study

    Not yet reported The Catholic University of Korea 500 participants Est. completion 2011-02 1 site
    Other conditions: Diabetes Mellitus, Hypercholessterolemia
    View official trial listing →
  • Completed NCT NCT01245608

    Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

    Not yet reported Tehran University of Medical Sciences 2400 participants Est. completion 2018-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01250834

    LY2189265 and Atorvastatin Interaction Study

    Not yet reported Eli Lilly and Company 27 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01255852

    Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting

    Not yet reported Jinling Hospital, China 100 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: CVD
    View official trial listing →
  • Completed NCT NCT01257009

    Atorvastatin and Sympathetic Activity in Chronic Kidney Disease

    Not yet reported UMC Utrecht 10 participants Est. completion 2010-07 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01259284

    Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 2 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT01259791

    Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Statin Myopathy
    View official trial listing →
  • Completed NCT NCT01263938

    Modulation of Monocyte Activation by Atorvastatin in HIV Infection

    Not yet reported University of Pennsylvania 5 participants Est. completion 2017-10 1 site
    Other conditions: HIV Dementia
    View official trial listing →
  • Completed NCT NCT01271985

    Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

    Not yet reported Tehran University of Medical Sciences 8410 participants Est. completion 2019-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01278459

    Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?

    Not yet reported University of Oxford 11 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Completed NCT NCT01279590

    Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

    Not yet reported Furiex Pharmaceuticals, Inc 282 participants Est. completion 2011-11 67 sites
    Other conditions: Myalgia, Hypercholesterolemia, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01285544

    The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

    Not yet reported Seoul National University Hospital 289 participants Est. completion 2009-07 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01288443

    Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy

    Not yet reported Sanofi 183 participants Est. completion 2011-12 38 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01288469

    Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

    Not yet reported Sanofi 92 participants Est. completion 2011-09 20 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01293097

    Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI

    Not yet reported Peking University First Hospital 2884 participants Est. completion 2011-10 1 site
    Cardiovascular disease Other conditions: Unstable Angina Pectoris, Stable Angina Pectoris
    View official trial listing →
  • Completed NCT NCT01299181

    A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis

    Not yet reported University of Edinburgh 60 participants Est. completion 2013-08 1 site
    Other conditions: Bronchiectasis
    View official trial listing →
  • Completed NCT NCT01299194

    Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa

    Not yet reported University of Edinburgh 32 participants Est. completion 2017-05 1 site
    Other conditions: BRONCHIECTASIS
    View official trial listing →
  • Completed NCT NCT01299597

    A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.

    Not yet reported GlaxoSmithKline 30 participants Est. completion 2010-02-26 1 site Stand-alone
    Other conditions: Sleep Disorders
    View official trial listing →
  • Completed NCT NCT01304641

    Cardiovascular Events Based On Statin Initiation In The Elderly

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 31603 participants Est. completion 2011-02
    Other conditions: Cardiovascular, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01305317

    Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

    Not yet reported Hormozgan University of Medical Sciences 74 participants Est. completion 2010-01 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01306565

    High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)

    Not yet reported Hormozgan University of Medical Sciences 100 participants Est. completion 2011-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01318564

    Diabetic Treatment Adherence

    M.D. Anderson Cancer Center 28 participants Est. completion 2016-08 2 sites
    Other conditions: Endocrine System Diseases
    View official trial listing →
  • Status unknown NCT NCT01322711

    Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes

    Not yet reported University of Roma La Sapienza 60 participants Est. completion 2015-12 1 site
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01332747

    Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation

    Not yet reported Jamia Hamdard University 128 participants Est. completion 2011-05 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT01334671

    The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI

    Not yet reported General Hospital of Chinese Armed Police Forces 150 participants Est. completion 2013-03 1 site Stand-alone
    Cardiovascular disease Other conditions: (STEMI)
    View official trial listing →
  • Completed NCT NCT01335048

    Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity

    Not yet reported Ospedale Misericordia e Dolce 50 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Stable Angina
    View official trial listing →
  • Terminated NCT NCT01341730

    The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)

    Not yet reported The Catholic University of Korea 41 participants Est. completion 2012-08 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01342211

    A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

    Not yet reported Pfizer 93 participants Est. completion 2012-06 44 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01350141

    A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

    Not yet reported Pfizer 46 participants Est. completion 2012-06 35 sites
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01351025

    Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 98 participants Est. completion 2014-05 31 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT01352897

    Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

    AstraZeneca 800 participants Est. completion 2010-12 1 site
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT01363999

    A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 24 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01370590

    A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

    Not yet reported Organon and Co 406 participants Est. completion 2012-04 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01370603

    A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

    Not yet reported Organon and Co 328 participants Est. completion 2012-05 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01372839

    Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome

    Not yet reported Xijing Hospital 300 participants 1 site
    Cardiovascular disease Other conditions: Unstable Angina
    View official trial listing →
  • Completed NCT NCT01375075

    A Study of LY2484595 in Japanese Subjects

    Not yet reported Eli Lilly and Company 165 participants Est. completion 2012-03 5 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01385631

    Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

    Not yet reported Odense University Hospital 87 participants Est. completion 2014-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01386853

    Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

    Not yet reported Tai Tien Pharmaceuticals Co., Ltd. 200 participants Est. completion 2012-07 6 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT01394848

    Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy

    Not yet reported Yonsei University 1 participants Est. completion 2013-01 1 site
    Other conditions: Stable Angina
    View official trial listing →
  • Completed NCT NCT01431105

    Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

    Not yet reported, Not yet reported University of California, San Diego 34 participants Est. completion 2018-07 1 site Stand-alone
    Other conditions: Kawasaki Disease
    View official trial listing →
  • Withdrawn NCT NCT01442428

    Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial

    Not yet reported, Not yet reported University of Minnesota Est. completion 2016-06 3 sites Stand-alone
    Other conditions: Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome, Tuberculosis, HIV-infection/Aids
    View official trial listing →
  • Completed NCT NCT01442987

    Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

    Not yet reported Hanmi Pharmaceutical Company Limited 230 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01446679

    Special Drug Use-Results Survey of Lipitor Tablets

    Astellas Pharma Inc 24050 participants Est. completion 2012-03 8 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01447797

    A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

    Not yet reported Hanmi Pharmaceutical Company Limited 52 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01448174

    Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients

    Not yet reported Poznan University of Medical Sciences 310 participants Est. completion 2014-10 1 site
    Metabolic syndromeType 2 diabetes Other conditions: Renal Failure Chronic Requiring Hemodialysis, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01448642

    Statins Evaluation in Coronary Procedures and Revascularization Trial

    Not yet reported Hospital do Coracao 4191 participants Est. completion 2018-04 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT01455935

    Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention

    Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01477853

    A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

    Not yet reported Merck Sharp & Dohme LLC 166 participants Est. completion 2012-12-04 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01491256

    Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading

    Not yet reported The Korean Society of Circulation 100 participants Est. completion 2012-02 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01491958

    Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01492361

    A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

    Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01495013

    A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

    Not yet reported GlaxoSmithKline 427 participants Est. completion 2013-09 33 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01497912

    Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes

    Not yet reported Karolinska Institutet 20 participants Est. completion 2010-01 1 site
    Other conditions: Type 1 Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01499758

    A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.

    Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01499771

    A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01502943

    Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index

    Not yet reported Liaoning University of Traditional Chinese Medicine 480 participants Est. completion 2011-12 10 sites Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina Pectoris
    View official trial listing →
  • Status unknown NCT NCT01503671

    Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients

    Not yet reported National Taiwan University Hospital 36 participants Est. completion 2015-10 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT01507831

    Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)

    Not yet reported Sanofi 2341 participants Est. completion 2014-11 320 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01516879

    Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study

    Not yet reported Amgen 905 participants Est. completion 2013-10-14 96 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01518166

    Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

    Not yet reported Novo Nordisk A/S 70 participants Est. completion 2007-04 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Status unknown NCT NCT01518231

    Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

    Not yet reported Zhejiang Hospital 40 participants Est. completion 2013-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01525407

    Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 83 participants Est. completion 2016-02 3 sites Stand-alone
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT01526460

    Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention

    Not yet reported IRCCS San Raffaele 146 participants Est. completion 2014-02 1 site
    Other conditions: Platelet Dysfunction
    View official trial listing →
  • Completed NCT NCT01527045

    Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    Not yet reported Fred Hutchinson Cancer Center 47 participants Est. completion 2019-04 2 sites Stand-alone
    Other conditions: Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia, Loss of Chromosome 17p, Myelodysplastic/Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Aggressive Adult Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Withdrawn NCT NCT01527097

    Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

    Not yet reported shmuel fuchs Est. completion 2015-04 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01528709

    Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)

    Not yet reported Boca Raton Regional Hospital 173 participants Est. completion 2017-01 2 sites Stand-alone
    Other conditions: Saphenous Vein Graft Disease
    View official trial listing →
  • Completed NCT NCT01541943

    Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

    Not yet reported HanAll BioPharma Co., Ltd. 356 participants Est. completion 2014-11 1 site
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01543555

    Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose

    Not yet reported Hospital do Coracao 648 participants Est. completion 2015-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Peripheral Vascular Disease, Aortic Aneurism
    View official trial listing →
  • Completed NCT NCT01544309

    LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts

    Not yet reported Listen Trial Group 1049 participants 133 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01544751

    Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin

    Not yet reported Prof Antonino Belfiore 150 participants Est. completion 2015-06 1 site
    MASLD
    View official trial listing →
  • Completed NCT NCT01547455

    Safety and Efficiency Study of Loading Dose Atorvastatin in Cardiac Surgery

    Not yet reported Peking Union Medical College 96 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Status unknown NCT NCT01548326

    Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine

    Not yet reported Nematollah Jonaidi Jafari 52 participants Est. completion 2012-07 1 site
    Other conditions: Hepatitis B, Vaccination Failure
    View official trial listing →
  • Status unknown NCT NCT01550419

    Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke

    Not yet reported Shanghai Minhang Central Hospital 100 participants Est. completion 2014-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Ventilator-associated Pneumonia
    View official trial listing →
  • Withdrawn NCT NCT01555632

    Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

    Not yet reported University of Nebraska Est. completion 2013-02 Stand-alone
    Other conditions: Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01557075

    Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation

    Not yet reported Yonsei University 2000 participants Est. completion 2015-08 1 site
    Other conditions: Drug-eluting Stent (DES)
    View official trial listing →
  • Status unknown NCT NCT01558245

    Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis

    Not yet reported Jinling Hospital, China 99 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Cerebrovascular Disease
    View official trial listing →
  • Completed NCT NCT01563731

    Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

    Not yet reported Istituto Auxologico Italiano 200 participants Est. completion 2021-03-31 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Hypertension
    View official trial listing →
  • Status unknown NCT NCT01567774

    Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01567826

    Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy

    Not yet reported Annapoorna Kini 87 participants Est. completion 2012-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01569100

    Atorvastatin After Aneurysmal Subarachnoid Hemorrhage

    Groupe Hospitalier Pitie-Salpetriere 278 participants Est. completion 2007-12
    Other conditions: SAH
    View official trial listing →
  • Withdrawn NCT NCT01569854

    Genetic Influence on Statin Pharmacodynamics

    Ohio State University Est. completion 2022-03 1 site
    Other conditions: Hyperlipidemia, Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT01570530

    Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery

    Not yet reported Fundación General Universidad de Valladolid 90 participants Est. completion 2014-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT01572623

    Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting

    Not yet reported Campus Bio-Medico University 150 participants Est. completion 2012-09 1 site
    Other conditions: Carotid Stenosis
    View official trial listing →
  • Completed NCT NCT01581476

    Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

    Not yet reported University of Cambridge 443 participants Est. completion 2017-06 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01588795

    Renal Denervation in Diabetic Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2016-01 1 site
    Chronic kidney disease Other conditions: Persistent Proteinuria With Type II Diabetes
    View official trial listing →
  • Completed NCT NCT01600170

    Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)

    Not yet reported University of Pennsylvania 11 participants Est. completion 2017-10 1 site
    Other conditions: HIV Dementia
    View official trial listing →
  • Withdrawn NCT NCT01605344

    Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2014-07 1 site Stand-alone
    Other conditions: Advanced Adenocarcinoma of the Colon or Rectum
    View official trial listing →
  • Status unknown NCT NCT01617538

    Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis

    Not yet reported, Not yet reported Capital Medical University 30 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Stenosis
    View official trial listing →
  • Completed NCT NCT01617655

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)

    Not yet reported Sanofi 107 participants Est. completion 2015-01 35 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Status unknown NCT NCT01617772

    Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

    Not yet reported Tehran University of Medical Sciences 440 participants Est. completion 2019-12 2 sites Stand-alone
    Other conditions: Non-alcoholic Steatohepatitis
    View official trial listing →
  • Completed NCT NCT01623115

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

    Not yet reported Sanofi 486 participants Est. completion 2014-12 91 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01624207

    The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg

    Not yet reported Seoul National University Hospital 376 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01633359

    The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

    Not yet reported Ji Huang 300 participants Est. completion 2013-05 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01634906

    Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy

    Not yet reported Sint Franciscus Gasthuis 55 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Hyperlipidemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01635946

    Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

    Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Atorvastatin, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01644175

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)

    Not yet reported Sanofi 316 participants Est. completion 2014-04 76 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01644188

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)

    Not yet reported Sanofi 720 participants Est. completion 2015-07 126 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01645176

    Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee

    Not yet reported Stanford University 21 participants Est. completion 2016-10 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT01645384

    Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 69 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01645410

    Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 71 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01645423

    Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01645449

    Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01646307

    Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI

    Not yet reported Beijing Anzhen Hospital 1000 participants Est. completion 2013-06 1 site
    Other conditions: Focus of Study
    View official trial listing →
  • Status unknown NCT NCT01648829

    PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2017-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01660191

    A Study Comparing CoQ10 Levels While Taking 3 Different Statins

    Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01663402

    ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

    Not yet reported Sanofi 18924 participants Est. completion 2018-01-23 1388 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01665235

    Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

    Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Blood Pressure Variability, Intracranial Artery Stenosis
    View official trial listing →
  • Completed NCT NCT01665677

    Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

    Not yet reported Mehdi Hamadani 69 participants Est. completion 2021-07-09 2 sites Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT01673178

    Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

    Not yet reported Pfizer 107 participants Est. completion 2013-09 17 sites
    Other conditions: Diabetes Melliuts, Type 2
    View official trial listing →
  • Status unknown NCT NCT01674686

    The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

    Not yet reported Samsung Medical Center 200 participants Est. completion 2018-12-31 1 site Stand-alone
    Other conditions: Variant Angina
    View official trial listing →
  • Completed NCT NCT01686230

    Acupuncture in Patients With Stable Angina Pectoris

    Not yet reported Chengdu University of Traditional Chinese Medicine 404 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Angina, Stable
    View official trial listing →
  • Completed NCT NCT01689623

    A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 36 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT01692717

    Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

    Not yet reported Azidus Brasil 90 participants Est. completion 2013-05-31 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT01697735

    The Therapeutic Effects of Statins and Berberine on the Hyperlipemia

    Not yet reported Wenzhou Medical University 24 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01700075

    Physical and Chemical Study of Atherosclerosis Mechanisms

    Not yet reported Nazarbayev University 97 participants Est. completion 2011-12 1 site
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis of Femoral Artery
    View official trial listing →
  • Completed NCT NCT01702987

    Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

    Not yet reported Beth Israel Deaconess Medical Center 22 participants Est. completion 2013-10 1 site
    Other conditions: Myopathy, HMG COA Reductase Inhibitor Adverse Reaction, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01709500

    Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)

    Not yet reported Regeneron Pharmaceuticals 249 participants Est. completion 2015-01 24 sites Stand-alone
    Other conditions: Heterozygous Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01709513

    Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

    Not yet reported Regeneron Pharmaceuticals 314 participants Est. completion 2017-05-31 70 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01710007

    Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

    Not yet reported Orient Pharma Co., Ltd. 202 participants Est. completion 2012-11 8 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01715714

    Statin Recapture Therapy Before Coronary Artery Bypass Grafting

    Not yet reported University of Cologne 2630 participants Est. completion 2020-09-27 10 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01720719

    Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

    Not yet reported Xin Gao 120 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Fatty Liver, Dyslipidemias, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01730040

    Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

    Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01732718

    Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

    Not yet reported University of North Carolina, Chapel Hill 13 participants Est. completion 2018-01-09 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Sickle Cell Nephropathy
    View official trial listing →
  • Completed NCT NCT01733953

    Statin Therapy in Young Adult Survivors of Childhood Cancer

    Not yet reported University of Minnesota 27 participants Est. completion 2016-03 1 site Stand-alone
    Cardiovascular disease Other conditions: Childhood ALL, Childhood NHL
    View official trial listing →
  • Completed NCT NCT01748279

    The Effects of Atorvastatin Treatment in COPD Patients

    Not yet reported Medical University of Bialystok 18 participants Est. completion 2013-04 1 site
    Other conditions: COPD
    View official trial listing →
  • Status unknown NCT NCT01751295

    Statin and Post-interventional Coronary Microcirculation Dysfunction

    Not yet reported Samsung Medical Center 84 participants Est. completion 2014-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01759836

    Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

    Not yet reported Asan Medical Center 364 participants Est. completion 2021-09-30 1 site Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01761656

    Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR

    Not yet reported Central South University 180 participants Est. completion 2014-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Stable Angina, Unstable Angina
    View official trial listing →
  • Completed NCT NCT01763866

    LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

    Not yet reported Amgen 2067 participants Est. completion 2013-12-04 244 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01765023

    Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 80 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01766076

    Atorvastatin for HAART Suboptimal Responders

    Not yet reported Makerere University 30 participants Est. completion 2014-03 Stand-alone
    Other conditions: Acquired Immune Deficiency Syndrome Virus
    View official trial listing →
  • Completed NCT NCT01768481

    Intima Media Thickness Regression in Dyslipidemic Teenagers

    Not yet reported Université de Montréal 16 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Obesity, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01770210

    Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events

    Elpen Pharmaceutical Co. Inc. 670 participants Est. completion 2014-07 17 sites
    Other conditions: Cardiovascular Disorders
    View official trial listing →
  • Completed NCT NCT01779453

    A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

    Not yet reported Esperion Therapeutics, Inc. 58 participants Est. completion 2013-08 3 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01779687

    Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: HIV, Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT01780740

    Statin Therapy In Atrial Refractoriness and Reperfusion Injury

    Not yet reported University of Oxford 80 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Disorder; Heart, Functional, Postoperative, Cardiac Surgery, Cardiac Insufficiency Following Cardiac Surgery, Atrial Fibrillation, Ischaemia-reperfusion Injury
    View official trial listing →
  • Completed NCT NCT01780948

    Pharmacokinetic of Everolimus and Atorvastatin Co-administration

    Not yet reported Chulalongkorn University 18 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Difference of 12-hour AUC
    View official trial listing →
  • Completed NCT NCT01785615

    Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin

    Not yet reported, Not yet reported University of Rochester 116 participants Est. completion 2013-05 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT01795937

    Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin

    Not yet reported Boehringer Ingelheim 51 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01806324

    A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

    Not yet reported HanAll BioPharma Co., Ltd. 30 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01812707

    Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan

    Not yet reported Sanofi 100 participants Est. completion 2014-01 4 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01820767

    Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

    Not yet reported Ricardo Mouzo Mirco 31 participants Est. completion 2014-03 2 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01821404

    Atorvastatin Before Prostatectomy and Prostate Cancer

    Not yet reported Tampere University Hospital 160 participants Est. completion 2017-05 3 sites Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT01837069

    Risk Factor Control Before Orthopedic Surgery

    Not yet reported NYU Langone Health 198 participants Est. completion 2018-04-02 1 site
    OsteoarthritisCardiovascular disease
    View official trial listing →
  • Completed NCT NCT01842230

    Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01842256

    Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01856374

    Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

    Not yet reported Yonsei University 60 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Multi-vessel Diseases, Angina
    View official trial listing →
  • Completed NCT NCT01857921

    Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery

    Not yet reported Yonsei University 290 participants Est. completion 2018-04-08 1 site Stand-alone
    Other conditions: Coronary Artery
    View official trial listing →
  • Completed NCT NCT01859455

    Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

    Not yet reported Novartis Pharmaceuticals 25 participants Est. completion 2012-07 2 sites Stand-alone
    Other conditions: Hypercholesterolemia, LDL Cholesterol
    View official trial listing →
  • Terminated NCT NCT01863225

    Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

    Not yet reported Resverlogix Corp 13 participants Est. completion 2013-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01870804

    Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)

    Not yet reported Centro Cardiopatici Toscani 760 participants Est. completion 2016-09 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01890967

    A Study of LY3015014 in Participants With High Cholesterol

    Not yet reported Eli Lilly and Company 527 participants Est. completion 2014-06 49 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01922687

    Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

    Not yet reported Shanghai Institute of Hypertension 109 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Arterial and Arteriolar Disorders
    View official trial listing →
  • Status unknown NCT NCT01925079

    Intensive Education on Lipid Management

    Not yet reported Junbo Ge 2568 participants Est. completion 2015-06 5 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT01925937

    Atorvastatin/CoenzymeQ10 in Congestive Heart Failure

    Not yet reported Isfahan University of Medical Sciences 30 participants 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT01926782

    Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)

    Not yet reported Regeneron Pharmaceuticals 803 participants Est. completion 2015-04 83 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01929135

    Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.

    Not yet reported Universidad de los Andes, Chile 38 participants Est. completion 2014-06 2 sites Stand-alone
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Status unknown NCT NCT01936103

    Effects of Intensive Statin Treatment on Left Ventricular Function

    Not yet reported Shenyang Northern Hospital 120 participants Est. completion 2014-07 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01946815

    Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

    Not yet reported Keimyung University Dongsan Medical Center 119 participants Est. completion 2018-11 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01953328

    Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

    Not yet reported Amgen 409 participants Est. completion 2014-06 54 sites Stand-alone
    Other conditions: Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
    View official trial listing →
  • Completed NCT NCT01954394

    Open Label Study of Long Term Safety Evaluation of Alirocumab

    Not yet reported Sanofi 986 participants Est. completion 2017-06-30 177 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01956201

    Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

    Not yet reported Chong Kun Dang Pharmaceutical 476 participants Est. completion 2016-08 30 sites Stand-alone
    Other conditions: Mixed Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01964326

    Actual Use Trial of Atorvastatin Calcium 10 mg

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1311 participants Est. completion 2014-12 37 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01970215

    TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)

    Not yet reported Xention Ltd 364 participants Est. completion 2014-07 17 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT01972178

    Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

    Not yet reported Pronova BioPharma 113 participants Est. completion 2014-08 29 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT01974297

    Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

    Not yet reported Sang Hak Lee 194 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Mixed Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT01974544

    Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

    Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01980823

    Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

    Not yet reported Columbia University 23 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: Breast Cancer, Breast Tumors, Cancer of Breast
    View official trial listing →
  • Completed NCT NCT01984424

    Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3

    Not yet reported Amgen 511 participants Est. completion 2017-11-21 58 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Withdrawn NCT NCT01987310

    Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

    Not yet reported Sheba Medical Center Est. completion 2015-12 1 site
    Other conditions: Non Alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01988571

    Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

    Not yet reported Wake Forest University Health Sciences 279 participants Est. completion 2020-09-24 51 sites
    Other conditions: Breast Cancer, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01997294

    Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction

    Not yet reported Zhang Qi, MD 1200 participants Est. completion 2017-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02001883

    Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Suspended NCT NCT02022293

    Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 324 participants Est. completion 2024-01 6 sites
    Other conditions: Nasopharyngeal Carcinoma, Radiation Therapy Complication
    View official trial listing →
  • Status unknown NCT NCT02023892

    Single Dose of Atorvastatin and Circulating Endothelial Microparticles

    Not yet reported Sun Yat-sen University 30 participants Stand-alone
    Other conditions: Endothelium, Hydroxymethylglutaryl-CoA Reductase Inhibitors
    View official trial listing →
  • Completed NCT NCT02024373

    Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

    Not yet reported Oriental Neurosurgery Evidence-Based-Study Team 200 participants Est. completion 2016-09 31 sites Stand-alone
    Other conditions: Chronic Subdural Hematoma
    View official trial listing →
  • Completed NCT NCT02029118

    Acupoint Application in Patients With Stable Angina Pectoris (AASAP)

    Not yet reported Chengdu University of Traditional Chinese Medicine 200 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Stable Angina Pectoris
    View official trial listing →
  • Status unknown NCT NCT02029534

    Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

    Not yet reported Creighton University 200 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Cardiothoracic Surgery, Post-operative Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02029573

    Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma

    Not yet reported King Fahad Medical City 36 participants Est. completion 2016-12-31 1 site Stand-alone
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Status unknown NCT NCT02030054

    Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

    Not yet reported University of Roma La Sapienza 150 participants Est. completion 2015-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02035215

    Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 80 participants Est. completion 2014-12 4 sites Stand-alone
    Other conditions: Hyperlipidemia, Familial Combined
    View official trial listing →
  • Completed NCT NCT02055976

    Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

    Not yet reported Pfizer 218 participants Est. completion 2015-01 9 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02056340

    Statin Therapy in Acute Influenza

    Not yet reported Beth Israel Deaconess Medical Center 116 participants Est. completion 2018-06-30 1 site
    Other conditions: Influenza
    View official trial listing →
  • Completed NCT NCT02060032

    1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 96 participants Est. completion 2013-11
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02066207

    CKD-337 Drug Interaction Study

    Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2014-05-29 1 site Stand-alone
    Other conditions: Dyslipidemia (Fredrickson Type Ⅱa), Dyslipidemia (Fredrickson Type Ⅱb)
    View official trial listing →
  • Completed NCT NCT02069821

    Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 56 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02072161

    Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

    Not yet reported Esperion Therapeutics, Inc. 133 participants Est. completion 2015-01 40 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02080455

    Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.

    Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-03-07 1 site Stand-alone
    Other conditions: Effect of Atorvastatin on the Pharmacokinetics of Lomitapide
    View official trial listing →
  • Completed NCT NCT02081638

    Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 53 participants Est. completion 2019-10-16 2 sites
    Other conditions: Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02084069

    Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

    Not yet reported Urmia University of Medical Sciences 58 participants Est. completion 2014-04 1 site
    Other conditions: Heart Valve Diseases
    View official trial listing →
  • Completed NCT NCT02089061

    Drug Interaction Statin

    Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 Stand-alone
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT02093390

    A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

    Not yet reported Millennium Pharmaceuticals, Inc. 40 participants Est. completion 2014-04 Stand-alone
    Other conditions: Prostate Cancer, Endometriosis
    View official trial listing →
  • Completed NCT NCT02094313

    Effects of Atorvastatin on Human Semen and Gonadal Hormones

    Not yet reported University Hospital, Clermont-Ferrand 17 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy Volunteers, Normocholesterolaemic Men, Normozoospermic Men
    View official trial listing →
  • Completed NCT NCT02097589

    The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23

    Not yet reported University of Florida 33 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Healthy Controls
    View official trial listing →
  • Completed NCT NCT02098460

    To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject

    Not yet reported Otsuka Beijing Research Institute 300 participants Est. completion 2016-03 1 site
    Other conditions: Severe Hypercholesterolemia
    View official trial listing →
  • Active, not recruiting NCT NCT02099123

    A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

    Not yet reported Monash University 9971 participants Est. completion 2025-12 6 sites Stand-alone
    Other conditions: Independent Living, Disability Free Survival, Elderly, Healthy
    View official trial listing →
  • Completed NCT NCT02107898

    Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

    Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02113540

    Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography

    Not yet reported Isfahan University of Medical Sciences 1 site Stand-alone
    Other conditions: Contrast Induced Nephropathy
    View official trial listing →
  • Status unknown NCT NCT02114099

    Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease

    Not yet reported National Taiwan University Hospital 20 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Kawasaki Disease, Aneurysm, Coronary
    View official trial listing →
  • Completed NCT NCT02114346

    High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 250 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Contrast-Induced Nephropathy
    View official trial listing →
  • Completed NCT NCT02119520

    PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS

    Not yet reported Government Dental College and Research Institute, Bangalore 96 participants Est. completion 2014-02 1 site
    Other conditions: Periodontitis
    View official trial listing →
  • Completed NCT NCT02125682

    The HDL Particle Protection Study

    Not yet reported Hotel Dieu de France Hospital 16 participants Est. completion 2017-05-14 1 site
    Other conditions: Dyslipidemia in Patients With Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02133534

    The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease

    Not yet reported Duke University 1 participants Est. completion 2009-05 Stand-alone
    Chronic kidney disease Other conditions: High Cholesterol
    View official trial listing →
  • Completed NCT NCT02133807

    Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis

    Not yet reported Russian Cardiology Research and Production Center 32 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Atherosclerosis, Coronary Disease, Carotid Artery Diseases
    View official trial listing →
  • Completed NCT NCT02135029

    Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

    Not yet reported Pfizer 184 participants Est. completion 2015-11 40 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02155530

    COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial

    Not yet reported Yonsei University 30 participants Est. completion 2016-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02156492

    A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants

    Not yet reported Eli Lilly and Company 62 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02157337

    The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery

    Not yet reported Yonsei University 23 participants Est. completion 2015-05-29 1 site Stand-alone
    Other conditions: Aortic Surgery, Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT02160743

    The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 28 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Food Effect Study of CJ-30056 20mg/500mg
    View official trial listing →
  • Completed NCT NCT02166593

    Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 302 participants Est. completion 2018-01 1 site Stand-alone
    Other conditions: Combined Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02171039

    Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02185066

    Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR

    Not yet reported HK inno.N Corporation 42 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02189837

    Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

    Not yet reported Amgen 89 participants Est. completion 2015-03-05 2 sites Stand-alone
    Other conditions: Primary Hyperlipidemia and Mixed Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT02192320

    The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders

    Not yet reported Oriental Neurosurgery Evidence-Based-Study Team 60 participants Est. completion 2015-09 2 sites Stand-alone
    Other conditions: Chronic Subdural Hematoma
    View official trial listing →
  • Completed NCT NCT02197065

    Pilot Study of Atorvastatin for Orthopedic Surgery Patients

    Not yet reported Hospital for Special Surgery, New York 20 participants Est. completion 2017-01 2 sites Stand-alone
    Other conditions: Hip Fracture, Myocardial Ischemia, Inflammation
    View official trial listing →
  • Withdrawn NCT NCT02201381

    Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer

    Not yet reported Health Clinics Limited Est. completion 2027-09-23 1 site Stand-alone
    Other conditions: Cancer, Overall Survival
    View official trial listing →
  • Terminated NCT NCT02205775

    Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty

    Not yet reported G. d'Annunzio University 280 participants Est. completion 2012-06 6 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02207634

    Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects

    Not yet reported Amgen 1974 participants Est. completion 2016-11-11 416 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT02219191

    Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

    Not yet reported Chengdu PLA General Hospital 150 participants Est. completion 2018-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02225834

    Atorvastatin in Acute Stroke Treatment

    Not yet reported University of Palermo 50 participants Est. completion 2014-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02227784

    A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

    Not yet reported Eli Lilly and Company 366 participants Est. completion 2015-12 64 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02243098

    Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04-07 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Terminated NCT NCT02245087

    Eliminate Coronary Artery Disease

    Not yet reported University Health Network, Toronto 28 participants Est. completion 2019-09 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02245269

    Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 23 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02254824

    Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 300 participants Est. completion 2016-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02260648

    A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

    Not yet reported Eli Lilly and Company 149 participants Est. completion 2015-11 8 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02278471

    The SCCS Polypill Pilot Trial

    Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02286544

    Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers

    Not yet reported Karolinska Institutet 36 participants Est. completion 2015-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Inflammation, Acute Coronary Syndrome (ACS), Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT02288338

    CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

    Not yet reported Chong Kun Dang Pharmaceutical 36 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02289963

    Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

    Not yet reported Sanofi 199 participants Est. completion 2016-04 27 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02292069

    Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition

    Not yet reported Dr. Reddy's Laboratories Limited 90 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02295046

    Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

    Not yet reported Dr. Reddy's Laboratories Limited 80 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02305355

    Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site Stand-alone
    Type 2 diabetes Other conditions: Hypertriglycemia
    View official trial listing →
  • Completed NCT NCT02314208

    Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 12 participants Est. completion 2018-01-01 1 site
    Other conditions: Spastic Paraplegia, Hereditary
    View official trial listing →
  • Status unknown NCT NCT02323425

    Effects of Limb Ischemic Postconditioning in Young sICAS

    Not yet reported Xi'an Jiaotong University 100 participants Est. completion 2018-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02331095

    Statin Use in Patients With Acute VTE

    Not yet reported Ohio State University 21 participants Est. completion 2020-05-20 1 site Stand-alone
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT02342015

    Effect of Atorvastatin on Bone-vascular Axis

    Not yet reported University of Padova 20 participants Est. completion 2014-03 Stand-alone
    Other conditions: Osteoporosis, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02347098

    Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II

    Not yet reported VA Office of Research and Development 270 participants Est. completion 2019-09-30 4 sites Stand-alone
    Other conditions: Acute Coronary Artery Syndrome
    View official trial listing →
  • Status unknown NCT NCT02350959

    Adverse Plaque Characteristics in CCTA and TVC Imaging

    Not yet reported National Health Insurance Service Ilsan Hospital 100 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Plaque
    View official trial listing →
  • Completed NCT NCT02355704

    Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney

    Not yet reported Instituto Mexicano del Seguro Social 48 participants Est. completion 2014-07 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT02357212

    Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome

    Not yet reported University of Florida 40 participants Est. completion 2013-09
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02363725

    Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response

    Not yet reported University Hospital, Montpellier 44 participants Est. completion 2016-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02364258

    Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients

    Not yet reported Children's Mercy Hospital Kansas City 28 participants Est. completion 2017-12-27 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02370784

    Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

    Not yet reported Robyn T. Domsic, MD, MPH 24 participants Est. completion 2019-12-15 1 site
    Other conditions: Scleroderma
    View official trial listing →
  • Completed NCT NCT02374047

    A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

    Not yet reported Catabasis Pharmaceuticals 118 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02378441

    Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg

    Not yet reported HK inno.N Corporation 42 participants Est. completion 2015-08 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02380625

    Multiple Treatments for Ebola Virus Disease (EVD)

    Not yet reported, Not yet reported Clinical Research Management, Inc. 150 participants Est. completion 2016-03 Stand-alone
    Other conditions: Ebola Virus Disease
    View official trial listing →
  • Completed NCT NCT02386033

    Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 60 participants Est. completion 2014-07
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02392416

    Atorvastatin Study in Cardiovascular Disease Risk

    Elpen Pharmaceutical Co. Inc. 900 participants Est. completion 2016-02 2 sites
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02397590

    Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 36 participants Est. completion 2015-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02411903

    The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

    Not yet reported The Third Affiliated Hospital of Guangzhou Medical University 160 participants Est. completion 2016-08
    Other conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)
    View official trial listing →
  • Status unknown NCT NCT02416427

    Targeting the Hippo Transducer TAZ in Breast Cancer With Statins

    Not yet reported Regina Elena Cancer Institute 78 participants Est. completion 2016-12 Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02422030

    CKD-337(2) Drug-drug Interaction Study

    Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2015-04-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02432040

    Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

    Not yet reported Philippine Dermatological Society 28 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02432534

    Atorvastatin in Active Vitiligo

    Not yet reported Centre Hospitalier Universitaire de Nice 28 participants Est. completion 2017-12 2 sites Stand-alone
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT02437084

    Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling

    Not yet reported Stanford University 115 participants Est. completion 2020-04 1 site
    Type 2 diabetes Other conditions: Hyperlipidemia, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02451098

    Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

    Not yet reported Chong Kun Dang Pharmaceutical 385 participants Est. completion 2016-01 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02452502

    The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 254 participants Est. completion 2018-08 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02455869

    Comparison of Alendronate With Atorvastatin in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 104 participants Est. completion 2015-03
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Status unknown NCT NCT02458755

    Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

    Not yet reported Samsung Medical Center 80 participants Est. completion 2018-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Intracranial Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02460159

    A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

    Not yet reported Organon and Co 135 participants Est. completion 2016-12-22
    Other conditions: Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02461004

    CKD-391 Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 52 participants Est. completion 2015-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02470455

    Effect of Atorvastatin on Glycemic Control in Prediabetic Patients

    Shri Ramachandra Bhanj Medical College 75 participants Est. completion 2012-12 1 site
    Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT02476006

    Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

    Not yet reported Sanofi 998 participants Est. completion 2019-04-12 153 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02496962

    Protective Effect of Statin on Sleep Deprivation

    Not yet reported Shi Yang 72 participants 1 site Stand-alone
    Other conditions: Sleep Deprivation
    View official trial listing →
  • Withdrawn NCT NCT02497638

    LIpitor and biGuanide to Androgen Delay Trial

    Not yet reported University Health Network, Toronto Est. completion 2022-12 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02501200

    CKD-391 Pharmacokinetic Study Phase I

    Not yet reported Chong Kun Dang Pharmaceutical 46 participants Est. completion 2015-12
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02503865

    Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

    Not yet reported, Not yet reported Nazarbayev University 351 participants Est. completion 2014-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02516111

    Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2015-05
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02518503

    High Potency Statins and the Risk of Diabetes

    Canadian Network for Observational Drug Effect Studies, CNODES 136966 participants Est. completion 2013-02
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT02518516

    High Potency Statins and Acute Kidney Injury

    Canadian Network for Observational Drug Effect Studies, CNODES 2067639 participants Est. completion 2013-01 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02522117

    Atorvastatin in the Recipient's Kidney Graft From a Living Donor

    Not yet reported Instituto Mexicano del Seguro Social 48 participants Est. completion 2018-01 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT02539810

    Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

    Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-07 15 sites Stand-alone
    Other conditions: Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent
    View official trial listing →
  • Completed NCT NCT02549846

    AdminiStration of Statin On Acute Ischemic stRoke patienT Trial

    Not yet reported Hyogo Medical University 270 participants Est. completion 2017-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02550288

    A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

    Not yet reported Organon and Co 309 participants Est. completion 2016-05-30 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02565615

    Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 5115 participants Est. completion 2018-08-31 54 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02566187

    A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

    Not yet reported Boryung Pharmaceutical Co., Ltd 99 participants Est. completion 2015-10 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02577042

    Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen

    Not yet reported Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 42 participants Est. completion 2018-06-04 1 site Stand-alone
    Other conditions: Aging-related Inflammation in HIV-infected Patients
    View official trial listing →
  • Completed NCT NCT02579356

    To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

    Not yet reported Samil Pharmaceutical Co., Ltd. 48 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Diseases of the Circulatory System, Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT02579499

    Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

    Not yet reported Yonsei University 4400 participants Est. completion 2022-11 1 site Stand-alone
    Other conditions: Coronary Artery Diseasse
    View official trial listing →
  • Completed NCT NCT02584504

    Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

    Not yet reported Sanofi 163 participants Est. completion 2018-01-09 30 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02586155

    Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

    Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-alone
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT02587416

    Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

    Not yet reported NeuroBo Pharmaceuticals Inc. 20 participants Est. completion 2002-12 Stand-alone
    Other conditions: Hypercholesteremia
    View official trial listing →
  • Status unknown NCT NCT02588235

    Ezetimibe and Atorvastatin Therapy on TCFA

    Not yet reported Xijing Hospital 100 participants Est. completion 2017-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02590653

    Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI

    Not yet reported Penza State University 200 participants Est. completion 2020-02 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02591836

    Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin

    Not yet reported NeuroBo Pharmaceuticals Inc. 277 participants Est. completion 2003-06 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02596126

    Secondary Prevention of Cardiovascular Disease in the Elderly Trial

    Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02600520

    Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 45 participants Est. completion 2015-05
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT02603328

    Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

    Not yet reported, Not yet reported University of Chicago 80 participants Est. completion 2025-03-31 1 site
    Other conditions: Cerebral Cavernous Malformation
    View official trial listing →
  • Completed NCT NCT02608697

    A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

    Not yet reported Catabasis Pharmaceuticals 153 participants Est. completion 2016-06 34 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02609711

    Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

    Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 90 participants 1 site
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT02612792

    Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 82 participants Est. completion 2015-08 1 site
    Other conditions: Furcation Defects
    View official trial listing →
  • Status unknown NCT NCT02614352

    Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

    Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 60 participants Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT02633956

    Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

    Not yet reported Intercept Pharmaceuticals 84 participants Est. completion 2018-03-12 22 sites Stand-alone
    MASH
    View official trial listing →
  • Completed NCT NCT02641899

    Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

    Not yet reported Intarcia Therapeutics 33 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02651753

    A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

    Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2016-05
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02659397

    A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

    Not yet reported Esperion Therapeutics, Inc. 68 participants Est. completion 2016-07 19 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02662569

    Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

    Not yet reported Amgen 986 participants Est. completion 2017-12-06 110 sites Stand-alone
    Other conditions: Diabetes, Hyperlipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02668016

    Self-Assessment Method for Statin Side-effects Or Nocebo

    Not yet reported Imperial College London 60 participants Est. completion 2020-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Adverse Effects, Hyperlipidemias
    View official trial listing →
  • Terminated NCT NCT02674204

    STOP Heart Disease in Breast Cancer Survivors Trial

    Not yet reported Cedars-Sinai Medical Center 2 participants Est. completion 2018-05-25 1 site Stand-alone
    Other conditions: Breast Cancer, Heart Disease, Cardiotoxicity, Myocardial Dysfunction
    View official trial listing →
  • Completed NCT NCT02679261

    Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 220 participants Est. completion 2021-02 10 sites Stand-alone
    Other conditions: Bicuspid Aortic Valve
    View official trial listing →
  • Completed NCT NCT02681653

    Study the Impact of Statins in Septic Shock

    Not yet reported Sanjay Gandhi Postgraduate Institute of Medical Sciences 40 participants Est. completion 2015-01 2 sites
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT02685462

    Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin

    Not yet reported Tobira Therapeutics, Inc. 36 participants Est. completion 2016-02-23 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02706860

    Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events

    Not yet reported Cairo University 94 participants Est. completion 2015-02 Stand-alone
    Other conditions: Coronary Artery Bypass Grafting
    View official trial listing →
  • Completed NCT NCT02714569

    A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia

    Not yet reported Eli Lilly and Company 60 participants Est. completion 2017-02-15 4 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT02715726

    Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

    Not yet reported Sanofi 615 participants Est. completion 2018-08-06 62 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02726555

    The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin

    Not yet reported Wenzhou Medical University 240 participants Est. completion 2026-05 1 site Stand-alone
    Other conditions: Dyslipidemia, Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT02740699

    CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 79 participants Est. completion 2022-03-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02749578

    Drug Interaction Study of MGL-3196 With Atorvastatin

    Not yet reported Madrigal Pharmaceuticals, Inc. 14 participants Est. completion 2016-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02764736

    Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)

    Not yet reported Albert Einstein Healthcare Network Est. completion 2017-03-22 Stand-alone
    Other conditions: Complication of Renal Dialysis
    View official trial listing →
  • Completed NCT NCT02767362

    A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

    Not yet reported UNC Lineberger Comprehensive Cancer Center 24 participants Est. completion 2019-09-26 1 site Stand-alone
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT02767401

    The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)

    Not yet reported The First Affiliated Hospital of Dalian Medical University 200 participants Est. completion 2018-12-15
    Other conditions: Hibernation, Myocardial, Complete Occlusion of Coronary Artery
    View official trial listing →
  • Completed NCT NCT02776956

    Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy

    Not yet reported xieruiqin 180 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02781064

    STATIN: Web-based Investigation of Side Effects

    Not yet reported London School of Hygiene and Tropical Medicine 200 participants Est. completion 2019-08-08 58 sites
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02790528

    Statin Therapy In Patients With Vasospastic Angina

    Not yet reported Seung-Jung Park Est. completion 2023-12 1 site Stand-alone
    Other conditions: Angina Pectoris, Variant, Statins, HMG-CoA
    View official trial listing →
  • Status unknown NCT NCT02791958

    Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

    Not yet reported Ferrer Internacional S.A. 528 participants Est. completion 2017-10 36 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02800174

    Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

    Not yet reported Beijing Jishuitan Hospital 103 participants Est. completion 2008-06 Stand-alone
    Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Completed NCT NCT02800902

    Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2016-02 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Terminated NCT NCT02819869

    The Combination Effect of Statin Plus Metformin on Relapse-free

    Not yet reported Taipei Medical University WanFang Hospital 3 participants Est. completion 2016-12-14 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02842359

    Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension

    Not yet reported Sanofi 11 participants Est. completion 2018-04-19 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02850081

    Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

    Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Completed NCT NCT02863185

    Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease

    Not yet reported Dong-A University 45 participants Est. completion 2020-12-31 2 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02901379

    Effect of 80-mg Atorvastatin on Myocardial Edema

    Not yet reported National Cardiovascular Center Harapan Kita Hospital Indonesia 40 participants Est. completion 2018-08 Stand-alone
    Other conditions: Myocardial Edema
    View official trial listing →
  • Completed NCT NCT02910778

    The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males

    Not yet reported Medical University of Vienna 32 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Ischemia
    View official trial listing →
  • Completed NCT NCT02913664

    Risk Reduction for Alzheimer's Disease

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02938949

    Alirocumab in Patients With Acute Myocardial Infarction

    Not yet reported Virginia Commonwealth University 20 participants Est. completion 2018-08-16 1 site
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02940366

    Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

    Not yet reported Seoul National University Hospital 500 participants Est. completion 2019-11-30 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02942602

    Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

    Not yet reported Yonsei University 58 participants Est. completion 2016-05-23 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02943590

    STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

    Not yet reported Massachusetts General Hospital 300 participants Est. completion 2023-10-11 4 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02947620

    Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

    Not yet reported Daewoong Pharmaceutical Co. LTD. 185 participants Est. completion 2017-02-27 1 site
    Other conditions: Type II Diabetes, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02957162

    The Effect on EPCs by Statin Loading in "All Comers" With an ACS

    Not yet reported University Hospitals of North Midlands NHS Trust 40 participants Est. completion 2017-09-25 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02958852

    A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

    Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02967653

    Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus

    Not yet reported Lady Davis Institute 60 participants Est. completion 2019-07-01 3 sites Stand-alone
    Other conditions: Lithium Use, Nephrogenic Diabetes Insipidus
    View official trial listing →
  • Completed NCT NCT02977065

    To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

    Not yet reported Chong Kun Dang Pharmaceutical 62 participants Est. completion 2018-01-30 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT02979704

    A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia

    Not yet reported, Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90 participants Est. completion 2017-07 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02984293

    Statin Immune Study

    Not yet reported University of Dundee 18 participants Est. completion 2017-11-03 1 site
    Other conditions: Drug Intolerance
    View official trial listing →
  • Completed NCT NCT02984982

    Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

    Not yet reported Sanofi 206 participants Est. completion 2018-07-27 39 sites Stand-alone
    Other conditions: Hypercholesterolemia, Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02994745

    A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

    Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT03004001

    Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome

    Not yet reported Gloria Vega 3 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT03009097

    Atorvastatin as an Adjunct to DFDBA in Intrabony Defects

    Not yet reported Kamineni Institute of Dental Sciences 26 participants Est. completion 2014-08
    Other conditions: Chronic Periaortitis, Intrabony Periodontal Defect
    View official trial listing →
  • Completed NCT NCT03018444

    The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

    Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2017-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors
    View official trial listing →
  • Active, not recruiting NCT NCT03024684

    Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

    Not yet reported Chiayi Christian Hospital 240 participants Est. completion 2027-01 6 sites Stand-alone
    Other conditions: HepatoCellular Carcinoma
    View official trial listing →
  • Completed NCT NCT03031119

    Multiple Ascending Dose and DDI Study

    Not yet reported Pfizer 62 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03037372

    Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial

    Not yet reported Makerere University 320 participants Est. completion 2022-12-31 Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Withdrawn NCT NCT03047538

    Fixed Combination for Lipid and Blood Pressure Control

    Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 site
    Other conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT03047772

    Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

    Not yet reported Yuejin Yang 124 participants Est. completion 2018-12-31 Stand-alone
    Cardiovascular disease Other conditions: Stem Cell Transplantation, Angioplasty, Transluminal, Percutaneous Coronary
    View official trial listing →
  • Completed NCT NCT03051100

    Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

    Not yet reported Esperion Therapeutics, Inc. 63 participants Est. completion 2017-07-05 11 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03054467

    Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina

    Not yet reported Kosin University Gospel Hospital 150 participants Est. completion 2019-04-28
    Other conditions: Quality of Life
    View official trial listing →
  • Status unknown NCT NCT03061487

    Influence of Statins in Artery Aneurysms

    University of Catanzaro 20 participants Est. completion 2018-04-27 1 site
    Other conditions: Statin, Aneurysm, Extracellular Matrix Alteration
    View official trial listing →
  • Withdrawn NCT NCT03066466

    Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

    Not yet reported Loyola University Est. completion 2021-02-28 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT03072082

    Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

    Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03072121

    Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

    Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03073863

    Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study

    Not yet reported Korea University Guro Hospital 10001 participants Est. completion 2007-05-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03079115

    High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting

    Not yet reported Beijing Hospital 130 participants Est. completion 2020-04-30 1 site
    Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Completed NCT NCT03110848

    Effects of Atorvastatin in Graves' Orbitopathy (GO)

    Not yet reported University of Pisa 88 participants Est. completion 2021-04-30 1 site Stand-alone
    Other conditions: Thyroid Associated Ophthalmopathy, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03122639

    Endothelial Function in Obstructive Sleep Apnea

    Not yet reported Columbia University 106 participants Est. completion 2021-05-07 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Active, not recruiting NCT NCT03127631

    A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

    Not yet reported McMaster University 5000 participants Est. completion 2026-12-31 61 sites
    Cardiovascular disease Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03133260

    A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery

    Parc de Salut Mar 800 participants Est. completion 2021-10-15 1 site
    Other conditions: Myocardium; Injury
    View official trial listing →
  • Suspended NCT NCT03176498

    Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.

    Not yet reported, Not yet reported Sclnow Biotechnology Co., Ltd. 40 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cerebral Infarction
    View official trial listing →
  • Status unknown NCT NCT03186404

    Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study

    Not yet reported University Health Network, Toronto 112 participants Est. completion 2023-12 1 site Stand-alone
    Heart failure Other conditions: Cancer, Cardiotoxicity
    View official trial listing →
  • Withdrawn NCT NCT03188978

    High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study

    Not yet reported, Not yet reported Albany Medical College Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Primary Arteriovenous Fistula Failure
    View official trial listing →
  • Status unknown NCT NCT03195153

    Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin

    Not yet reported University of Roma La Sapienza 200 participants Est. completion 2017-07-15 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03207698

    PRF+1% MF for Class II Mandibular Furcation Defects

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 75 participants Est. completion 2016-05 1 site
    Other conditions: Furcation Defects
    View official trial listing →
  • Completed NCT NCT03218293

    Thrombolysis and RIPC in Acute Ischemic Stroke

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 68 participants Est. completion 2020-10-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03228017

    Subclinical Cardiovascular Disease in Psoriatic Disease

    Not yet reported NYU Langone Health 63 participants Est. completion 2019-04-01 1 site
    Cardiovascular disease Other conditions: Thrombotic Vascular Disease
    View official trial listing →
  • Terminated NCT NCT03228238

    ANti-Oxidant in Variant Angina (ANOVA) Trial

    Not yet reported Seoul National University Hospital 320 participants Est. completion 2024-06-01 1 site Stand-alone
    Other conditions: Variant Angina
    View official trial listing →
  • Completed NCT NCT03228771

    Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)

    Not yet reported Ain Shams University 30 participants Est. completion 2018-08-15 1 site
    Other conditions: Socket Preservation
    View official trial listing →
  • Completed NCT NCT03231137

    Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

    Not yet reported Ain Shams University 50 participants Est. completion 2017-07-10 Stand-alone
    Other conditions: Alveolar Socket Preservations
    View official trial listing →
  • Completed NCT NCT03247400

    The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo

    Not yet reported, Not yet reported Nicolaus Copernicus University 24 participants Est. completion 2019-04-30 1 site
    Other conditions: Non-segmental Vitiligo
    View official trial listing →
  • Completed NCT NCT03255044

    Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure

    Not yet reported Ain Shams University 85 participants Est. completion 2019-04-01 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT03273972

    INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 30 participants Est. completion 2018-10-10 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT03275376

    Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

    Not yet reported Taichung Veterans General Hospital 34 participants Est. completion 2021-03-13 1 site Stand-alone
    Other conditions: Overall Survival, Tumor Responses
    View official trial listing →
  • Status unknown NCT NCT03289429

    Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery

    Not yet reported Assiut University 96 participants Est. completion 2018-02 1 site Stand-alone
    Other conditions: Arrhythmias
    View official trial listing →
  • Completed NCT NCT03308578

    Statins and CPAP in Adipose Tissue of OSA

    Not yet reported, Not yet reported Mayo Clinic 50 participants Est. completion 2023-12-12 1 site Stand-alone
    Other conditions: Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT03311841

    Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

    Not yet reported Merck Sharp & Dohme LLC 32 participants Est. completion 2018-08-02 2 sites Stand-alone
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Withdrawn NCT NCT03318484

    Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication

    Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University Est. completion 2019-11 Stand-alone
    Cardiovascular disease Other conditions: Peripheral Arterial Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT03338426

    A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia

    Not yet reported Boryung Pharmaceutical Co., Ltd 133 participants Est. completion 2019-04-22 1 site Stand-alone
    Other conditions: Essential Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT03346187

    A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

    Not yet reported Chong Kun Dang Pharmaceutical 60 participants Est. completion 2017-06-13 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03351998

    Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity

    Not yet reported University of Kansas Medical Center 68 participants Est. completion 2023-07-07 2 sites
    Other conditions: Mitochondrial Diseases
    View official trial listing →
  • Status unknown NCT NCT03355027

    Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2023-11-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT03358017

    Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

    Not yet reported Mario Negri Institute for Pharmacological Research 54 participants Est. completion 2023-07-25 9 sites Stand-alone
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03360916

    Impact of Statin Therapy on Adaptations to Aerobic Exercise

    Not yet reported University of Kansas Medical Center 52 participants Est. completion 2024-06-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03370705

    Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

    Not yet reported Alfa Wassermann Tunisia 156 participants Est. completion 2020-03-30 3 sites
    Other conditions: Peripheral Arterial Obstructive Disease
    View official trial listing →
  • Status unknown NCT NCT03372785

    The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease

    Beijing Anzhen Hospital 240 participants Est. completion 2022-04 1 site
    Cardiovascular disease Other conditions: Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Viable Myocardium
    View official trial listing →
  • Completed NCT NCT03382756

    A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

    Not yet reported Chong Kun Dang Pharmaceutical 16 participants Est. completion 2017-11-07 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03391830

    Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy

    Not yet reported Mansoura University 250 participants Est. completion 2020-01-01 1 site
    Other conditions: Contrast-induced Nephropathy, Statin, Ascorbic Acid, AKI
    View official trial listing →
  • Completed NCT NCT03411291

    Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study

    Cedars-Sinai Medical Center 18 participants Est. completion 2010-09 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Status unknown NCT NCT03414840

    Assessment of Change in Atherosclerotic Plaque by Serial CCTA

    Yonsei University 400 participants Est. completion 2020-10-31 1 site
    Cardiovascular disease Other conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT03415178

    Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

    Not yet reported Sanofi 69 participants Est. completion 2018-08-09 13 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Active, not recruiting NCT NCT03417388

    Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

    Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03418974

    Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

    Not yet reported Fudan University 10000 participants Est. completion 2021-12-31 2 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03431909

    Evaluation Of HUK in Acute Stroke Patients: MRS and CTP

    Not yet reported Xuanwu Hospital, Beijing 80 participants Est. completion 2016-10-01
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03433196

    Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

    Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 255 participants Est. completion 2018-10-10 Stand-alone
    Other conditions: Hypercholesterolemia in Coronaory Heart Disease
    View official trial listing →
  • Status unknown NCT NCT03438955

    Phase I Drug-drug Interaction of Omega-3 and Atorvastatin

    Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 site
    Other conditions: Hyperlipidemia, Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT03460808

    The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

    Not yet reported, Not yet reported Peking University People's Hospital 200 participants Est. completion 2023-01-01 1 site Stand-alone
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT03461081

    Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 32 participants Est. completion 2017-12-12 1 site Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT03464682

    Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia

    Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 720 participants Est. completion 2019-05-28 Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03482180

    Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled

    Not yet reported Kuhnil Pharmaceutical Co., Ltd. 215 participants Est. completion 2018-03-23
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03504735

    Caduet and TLC Intervention in Metabolic Syndrome

    Not yet reported The University of Texas Medical Branch, Galveston 53 participants Est. completion 2016-02-28
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT03507374

    PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis

    Not yet reported University of Utah 20 participants Est. completion 2020-04-17 1 site
    Cardiovascular disease Other conditions: Intracranial Atherosclerosis, Intraplaque Hemorrhage
    View official trial listing →
  • Completed NCT NCT03510715

    An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

    Not yet reported Sanofi 18 participants Est. completion 2020-02-17 10 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03510884

    An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

    Not yet reported Sanofi 153 participants Est. completion 2022-08-05 43 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT03515772

    Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients

    Centre Hospitalier Universitaire Vaudois 21 participants Est. completion 2019-08-29 2 sites
    Cardiovascular disease Other conditions: HIV Infections, Drug Interactions
    View official trial listing →
  • Status unknown NCT NCT03532620

    China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension

    Not yet reported Jun Tao 396 participants Est. completion 2020-09 13 sites
    Other conditions: Prediabetic State, Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03541109

    A Polypill for Secondary Prevention of Ischemic Heart Disease

    Not yet reported Isfahan University of Medical Sciences 1200 participants Est. completion 2024-08 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT03560882

    A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

    Not yet reported Joaquina Baranda 50 participants Est. completion 2026-08-01 1 site Stand-alone
    Other conditions: Malignant Disease, Solid Tumor, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Cancer, Relapsed Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT03570697

    Imaging of Coronary Plaques in Participants Treated With Evolocumab

    Not yet reported Amgen 164 participants Est. completion 2021-01-21 33 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03604471

    Lipid-lowering Therapy Individualization

    Not yet reported Université Catholique de Louvain 75 participants Est. completion 2019-08-27 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03610217

    Pragmatic Clinical Trials in Scleroderma

    Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Scleroderma, Systemic, Sclerosis, Systemic
    View official trial listing →
  • Status unknown NCT NCT03610321

    Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

    Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 70 participants Est. completion 2021-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03611010

    Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

    Not yet reported Cumberland Pharmaceuticals 40 participants Est. completion 2020-02-24 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Withdrawn NCT NCT03625089

    Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis

    Not yet reported Chinese University of Hong Kong Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic
    View official trial listing →
  • Status unknown NCT NCT03635749

    Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis

    Not yet reported Beijing Tiantan Hospital 6100 participants Est. completion 2023-10-30 113 sites
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Status unknown NCT NCT03639480

    Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

    Not yet reported HK inno.N Corporation 180 participants Est. completion 2018-10 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03657472

    Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

    Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03660293

    Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

    Not yet reported Tanta University 150 participants Est. completion 2019-06-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT03692754

    Atorvastatin in Management of Newly Diagnosed ITP

    Not yet reported, Not yet reported Shandong University 30 participants Est. completion 2023-12-01 1 site
    Other conditions: Immune Thrombocytopenia, Purpura, Thrombocytopenic
    View official trial listing →
  • Status unknown NCT NCT03696940

    Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

    Not yet reported Laboratorios Grossman, S.A. 120 participants Est. completion 2019-08-31 1 site Stand-alone
    Other conditions: Dyslipidemias, Cardiovascular Risk Factor
    View official trial listing →
  • Status unknown NCT NCT03703635

    Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis

    Not yet reported Ministry of Science and Technology of the People´s Republic of China 512 participants Est. completion 2025-05 31 sites Stand-alone
    Other conditions: Intracranial Artery Stenosis
    View official trial listing →
  • Completed NCT NCT03709355

    Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

    Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Completed NCT NCT03745300

    Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.

    Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2017-12-22 1 site
    Other conditions: Chronic Periodontitis Wth Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT03750760

    Early Alirocumab to Reduce LDL-C in Myocardial Infarction

    Not yet reported Imperial College London Est. completion 2021-12 17 sites
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03760848

    Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers

    Not yet reported Galmed Pharmaceuticals Ltd 15 participants Est. completion 2019-02-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03768427

    Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

    Not yet reported Organon and Co 454 participants Est. completion 2021-04-01 30 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03769870

    Teneligliptin and Atorvastatin DDI Study

    Not yet reported Handok Inc. 30 participants Est. completion 2019-02-25 1 site
    Other conditions: Diabete Mellitus
    View official trial listing →
  • Completed NCT NCT03784703

    Type 2 Diabetic Patients Maintained on Statin Therapy

    Not yet reported Damanhour University 160 participants Est. completion 2020-01-31 1 site Stand-alone
    Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03801733

    Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

    Not yet reported Akebia Therapeutics 134 participants Est. completion 2018-11-24 1 site Stand-alone
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Terminated NCT NCT03820466

    Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

    Not yet reported Dr. med. Mahir Karakas 68 participants Est. completion 2022-04-07 7 sites Stand-alone
    Other conditions: Acute Chest Syndrome
    View official trial listing →
  • Completed NCT NCT03830164

    Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2022-11-02 1 site Stand-alone
    Other conditions: Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE, Impotence
    View official trial listing →
  • Completed NCT NCT03837925

    Pharmaco-metabolomic Effects of Statins: METASTATINE

    Not yet reported French Cardiology Society 120 participants Est. completion 2022-12-21 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03860220

    The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

    Not yet reported Hyo-Soo Kim 252 participants Est. completion 2023-09-07 9 sites
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03867110

    An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

    Not yet reported Organon and Co 628 participants Est. completion 2001-07-27 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03867318

    Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

    Not yet reported Organon and Co 621 participants Est. completion 2001-11-16 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03867994

    Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.

    Not yet reported rabab ahmed mohamed 144 participants Est. completion 2017-05-15 Stand-alone
    Other conditions: Contrast-induced Nephropathy
    View official trial listing →
  • Terminated NCT NCT03872388

    Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2023-10-19 5 sites Stand-alone
    Other conditions: Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative, Inflammatory Breast Carcinoma, Progesterone Receptor Negative, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03874156

    MUscle Side-Effects of Atorvastatin in Coronary Patients

    Not yet reported Vestre Viken Hospital Trust 77 participants Est. completion 2019-12-12 2 sites
    Other conditions: Statin Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT03874260

    Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

    Not yet reported Daewon Pharmaceutical Co., Ltd. 180 participants Est. completion 2020-03-31 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03877783

    DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes

    Not yet reported Umeå University 10 participants Est. completion 2023-06-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03882892

    Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

    Not yet reported Organon and Co 400 participants Est. completion 2002-08-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03882996

    A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

    Not yet reported Organon and Co 432 participants Est. completion 2003-02-04 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03884452

    Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

    Not yet reported Organon and Co 50 participants Est. completion 2001-05-24 Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03885921

    Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)

    Not yet reported Organon and Co 44 participants Est. completion 2003-07-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03906539

    Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

    Not yet reported All India Institute of Medical Sciences, Bhubaneswar 150 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03929744

    A Study of LY3502970 in Healthy Participants

    Not yet reported Eli Lilly and Company 133 participants Est. completion 2020-11-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03943459

    Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease

    Not yet reported InCor Heart Institute 60 participants Est. completion 2022-06-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03951207

    Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

    Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 site
    Other conditions: Dyslipidemias, Hypertension
    View official trial listing →
  • Status unknown NCT NCT03956368

    Efficacy of Atorvastatin in Chronic Subdural Haematoma

    Not yet reported Chinese University of Hong Kong 690 participants Est. completion 2023-03-16 7 sites Stand-alone
    Other conditions: Chronic Subdural Hematoma
    View official trial listing →
  • Completed NCT NCT03966859

    7-day Atorvastatin and Emotional Processing

    Not yet reported University of Oxford 50 participants Est. completion 2020-02-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03967496

    Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors

    Sultan Qaboos University 402 participants Est. completion 2019-03-31 1 site
    Other conditions: Delirium, Anesthesia; Adverse Effect
    View official trial listing →
  • Status unknown NCT NCT03971019

    Survival Benefits of Statins in Breast Cancer Patients

    Not yet reported Peking Union Medical College Hospital 314 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT04026230

    Impact of Atorvastatin on Prostate Cancer Progression During ADT

    Not yet reported Tampere University Hospital 400 participants Est. completion 2025-12-31 10 sites Stand-alone
    Other conditions: Metastatic Prostate Cancer, Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04047940

    A Study of LY900020 in Healthy Chinese Participants

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-02-18 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04056039

    Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.

    Not yet reported Hospital Central "Dr. Ignacio Morones Prieto" 60 participants Est. completion 2019-06-30 1 site
    Cardiovascular disease Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Terminated NCT NCT04072601

    Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis

    Not yet reported Copenhagen University Hospital, Hvidovre 78 participants Est. completion 2023-01-10 1 site Stand-alone
    Other conditions: Liver Cirrhoses
    View official trial listing →
  • Completed NCT NCT04087382

    Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window

    Not yet reported Assiut University 57 participants Est. completion 2019-10-20 2 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04091412

    Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

    Not yet reported The Second Hospital of Hebei Medical University 500 participants Est. completion 2020-05-01 1 site Stand-alone
    Other conditions: Collateral Circulation, Large-artery Occlusion, Cerebral Infarction
    View official trial listing →
  • Status unknown NCT NCT04100434

    Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome

    Not yet reported Tianjin Chest Hospital 500 participants Est. completion 2023-06-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
    View official trial listing →
  • Status unknown NCT NCT04101136

    Effect of Atorvastatin on Subclinical Atherosclerosis

    Not yet reported Dr Cipto Mangunkusumo General Hospital 80 participants Est. completion 2021-07-15 1 site
    Other conditions: CMV
    View official trial listing →
  • Active, not recruiting NCT NCT04111419

    Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

    Not yet reported Shanghai Jiao Tong University School of Medicine 1200 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04148820

    One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2021-10-31 2 sites Stand-alone
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Status unknown NCT NCT04149483

    Statin Treatment for UnruptureD Intracranial anEurysms Study

    Not yet reported Beijing Neurosurgical Institute 60 participants Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: Intracranial Aneurysm, Inflammation Vascular
    View official trial listing →
  • Status unknown NCT NCT04151355

    Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis

    Not yet reported Ain Shams University 100 participants Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04181749

    Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography

    Not yet reported University of Leicester 200 participants Est. completion 2024-01-31 3 sites
    Other conditions: Cardiovascular Risk Factor
    View official trial listing →
  • Status unknown NCT NCT04215237

    How Atorvastatin Affects the Gut Flora and Metabolomics?

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 30 participants Est. completion 2021-06-01 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04221321

    Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

    Not yet reported HK inno.N Corporation 32 participants Est. completion 2020-04-20 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04245046

    Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin

    Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-02-18 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04251364

    Treatment of Chronic Mountain Sickness

    Not yet reported Centre d'Expertise sur l'Altitude EXALT 60 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Hypoxia, Altitude
    View official trial listing →
  • Completed NCT NCT04262765

    Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

    Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-03-26 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04270370

    A Study of LY3478045 in Healthy Participants

    Not yet reported Eli Lilly and Company 72 participants Est. completion 2021-06-23 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04306627

    Effect of Atorvastatin on Carotid Intima Media Thickness

    Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28
    Other conditions: Essential Hypertension, Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT04325009

    Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"

    Not yet reported Dong-A ST Co., Ltd. 56 participants Est. completion 2020-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04333407

    Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

    Not yet reported Imperial College London 320 participants Est. completion 2021-11-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04369664

    CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

    Not yet reported NYU Langone Health 151 participants Est. completion 2023-10-19 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04375787

    Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention

    Not yet reported Mohamed Abdelfatah 200 participants Est. completion 2020-06-02 1 site
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT04379999

    Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

    Not yet reported Fox Chase Cancer Center 43 participants Est. completion 2025-08-04 1 site
    Other conditions: Lynch Syndrome
    View official trial listing →
  • Status unknown NCT NCT04380402

    Atorvastatin as Adjunctive Therapy in COVID-19

    Not yet reported Mount Auburn Hospital 300 participants Est. completion 2022-05-08 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04388501

    A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants

    Not yet reported Janssen Pharmaceutica N.V., Belgium 23 participants Est. completion 2021-10-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04425590

    The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

    Not yet reported, Not yet reported Duta Wacana Christian University 180 participants Est. completion 2020-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04434365

    Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

    Not yet reported, Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2020-12-30 1 site
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT04453735

    MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study

    Not yet reported Vestre Viken Hospital Trust 27 participants Est. completion 2020-12-18 2 sites
    Other conditions: Statin Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT04455581

    A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 8 participants Est. completion 2021-08-31 Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04466241

    Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

    Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 294 participants Est. completion 2021-11-01 2 sites Stand-alone
    Other conditions: COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2
    View official trial listing →
  • Completed NCT NCT04472637

    Atorvastatin Effects On Arterial Stiffness In Hemodialysis

    Not yet reported Alexandria University 50 participants Est. completion 2021-07-01 1 site Stand-alone
    Other conditions: Arterial Stiffness
    View official trial listing →
  • Completed NCT NCT04486508

    Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

    Not yet reported Rajaie Cardiovascular Medical and Research Center 600 participants Est. completion 2021-07-05 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04511000

    Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

    Not yet reported Chong Kun Dang Pharmaceutical 250 participants Est. completion 2019-05-20 10 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Active, not recruiting NCT NCT04536870

    Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study

    Not yet reported Monash University 369 participants Est. completion 2026-12 2 sites
    Heart failure Other conditions: Atrial Fibrillation, Healthy Ageing, Hypercholesterolemia, Myocardial Dysfunction
    View official trial listing →
  • Active, not recruiting NCT NCT04575857

    Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression

    University of Washington 100 participants Est. completion 2040-02 1 site
    Other conditions: Rheumatic Heart Disease, Valvular Disease
    View official trial listing →
  • Status unknown NCT NCT04581759

    Endovascular Treatment and RIPC in Acute Ischemic Stroke

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-10-30 1 site
    Cardiovascular disease Other conditions: Endovascular Treatment
    View official trial listing →
  • Terminated NCT NCT04591808

    Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

    Not yet reported Institut de Recherches Internationales Servier 146 participants Est. completion 2022-04-08 43 sites Stand-alone
    Other conditions: Dyslipidemias, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04607447

    Low Intracranial Pressure Treatment Strategies for Chronic Subdural Hematoma Patients

    Not yet reported Huashan Hospital 160 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: Chronic Subdural Hematoma
    View official trial listing →
  • Completed NCT NCT04608344

    Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants

    Not yet reported Gilead Sciences 27 participants Est. completion 2021-01-13 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04626973

    Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

    Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04631536

    Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC

    Not yet reported Lebanese American University Medical Center 42 participants Est. completion 2022-07-01 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Active, not recruiting NCT NCT04656028

    Genetic Testing and Motivational Counseling for FH

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 180 participants Est. completion 2025-03-30 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2, Hypercholesterolemia, Familial, 3, Hypercholesterolemia, Familial, 4, Hypercholesterolemia, Familial, 4, Autosomal Recessive, Familial Hypercholesterolemia With Hyperlipemia, Hypercholesterolemia, Autosomal Dominant, Type B, Hypercholesterolemia, Autosomal Dominant, Hypercholesterolemia, Autosomal Dominant, 3, Apolipoprotein B-100, Familial Defective, Genetic Testing, Motivational Interviewing, Therapeutic Adherence, Therapeutic Adherence and Compliance, Treatment Adherence, Medication Adherence, Treatment Adherence and Compliance, Patient Adherence, Compliance, Patient Compliance, Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Adherence, Patient, Adherence, Medication, Adherence
    View official trial listing →
  • Status unknown NCT NCT04661709

    Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 502 participants Est. completion 2023-06-01 Stand-alone
    Other conditions: Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine
    View official trial listing →
  • Completed NCT NCT04666389

    The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases

    Not yet reported I.M. Sechenov First Moscow State Medical University 150 participants Est. completion 2023-01-10 1 site
    Cardiovascular disease Other conditions: Contrast-induced Acute Kidney Injury
    View official trial listing →
  • Active, not recruiting NCT NCT04679376

    Statins for the Treatment of NASH

    Not yet reported Mayo Clinic 70 participants Est. completion 2026-12 2 sites Stand-alone
    MASH
    View official trial listing →
  • Status unknown NCT NCT04685642

    Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model

    Not yet reported Taipei Veterans General Hospital, Taiwan 180 participants Est. completion 2023-07-31 1 site
    Other conditions: Mood Disorder
    View official trial listing →
  • Status unknown NCT NCT04701242

    Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"

    Not yet reported Cairo University 500 participants Est. completion 2025-12 1 site
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04718155

    Could Early Atorvastatin Offer Anti Inflammatory Effects Upon Brain in Traumatic Head Injury?

    Not yet reported Assiut University 30 participants Est. completion 2022-06-01 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT04721795

    Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

    Not yet reported, Not yet reported Obafemi Awolowo University Teaching Hospital 150 participants Est. completion 2022-06-30 2 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT04737408

    Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

    Not yet reported Bjarne Linde Noergaard 120 participants Est. completion 2023-08 3 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04744571

    Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

    Not yet reported Beijing Anzhen Hospital 200 participants Est. completion 2023-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary Intervention, Chronic Total Occlusion of Coronary Artery, Drug-Eluting Stents
    View official trial listing →
  • Completed NCT NCT04747847

    Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

    Not yet reported University of California, San Diego 5 participants Est. completion 2022-08-17 1 site Stand-alone
    Other conditions: Kawasaki Disease
    View official trial listing →
  • Status unknown NCT NCT04754789

    Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI

    Not yet reported Assiut University 160 participants Est. completion 2021-03-01
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT04764851

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

    Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Active, not recruiting NCT NCT04767984

    Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

    Not yet reported Northwestern University 42 participants Est. completion 2026-11-30 3 sites Stand-alone
    Other conditions: Colorectal Carcinoma, Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT04789057

    Atorvastatin Effect on Reduction of COPD Exacerbations

    Not yet reported Medical University of Bialystok 460 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Copd, COPD Exacerbation, Smoking, Gene Expression, Atorvastatin
    View official trial listing →
  • Status unknown NCT NCT04801940

    HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 2631 participants Est. completion 2024-01-31 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04813471

    Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH

    Not yet reported Lebanese American University Medical Center 70 participants Est. completion 2021-04-30 1 site Stand-alone
    Other conditions: Covid19, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT04824911

    Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

    Not yet reported Chang Gung Memorial Hospital 376 participants Est. completion 2025-02-28 1 site Stand-alone
    Cardiovascular disease Other conditions: Dual Antiplatelet Therapy, Statin
    View official trial listing →
  • Completed NCT NCT04829149

    Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

    Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04850001

    Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

    Anhui Medical University 40 participants Est. completion 2025-12-31 1 site
    Other conditions: Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical Treatment
    View official trial listing →
  • Completed NCT NCT04851769

    Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography

    Not yet reported Beijing Anzhen Hospital 60 participants Est. completion 2021-03-01 1 site Stand-alone
    Other conditions: Randomized Controlled Trials
    View official trial listing →
  • Status unknown NCT NCT04857632

    Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage

    Not yet reported, Not yet reported Capital Medical University 98 participants Est. completion 2024-11-30 3 sites Stand-alone
    Other conditions: Intracerebral Hemorrhage, Statins
    View official trial listing →
  • Active, not recruiting NCT NCT04862260

    Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

    Not yet reported CHU de Quebec-Universite Laval 3 participants Est. completion 2026-12-31 2 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT04863274

    Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

    The League of Clinical Research, Russia 2912 participants Est. completion 2020-10-15 1 site
    Other conditions: Lipid Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT04882293

    Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

    Not yet reported Laboratorios Silanes S.A. de C.V. 78 participants Est. completion 2022-05 1 site Stand-alone
    Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04895098

    Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD

    Akrikhin 1000 participants Est. completion 2022-07-08 31 sites
    Cardiovascular disease Other conditions: Lipid Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT04900155

    Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19

    Not yet reported Penza State University 45 participants Est. completion 2024-12 1 site
    Other conditions: STEMI, Covid19, NSTEMI
    View official trial listing →
  • Active, not recruiting NCT NCT04904536

    Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

    Not yet reported The George Institute 190 participants Est. completion 2025-07-30 1 site Stand-alone
    Other conditions: Neurocognitive Impairment, Mild
    View official trial listing →
  • Withdrawn NCT NCT04922424

    Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men

    Not yet reported Yale University Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT04925219

    REmotely Supervised Exercise Therapy Trial 2

    Not yet reported Mid and South Essex NHS Foundation Trust 40 participants Est. completion 2024-12 1 site Stand-alone
    Alcohol use disorder Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Status unknown NCT NCT04943783

    Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

    Not yet reported Beijing Neurosurgical Institute 40 participants Est. completion 2022-07-30 2 sites Stand-alone
    Other conditions: Dissecting Aneurysm of Cerebral Artery, Intramural Hematomas, Inflammation Vascular
    View official trial listing →
  • Status unknown NCT NCT04945122

    Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 900 participants Est. completion 2023-12-31 1 site
    Cardiovascular disease Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT04952350

    Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT

    Not yet reported Mansoura University 220 participants Est. completion 2022-04 1 site
    Other conditions: Covid19, SARS-CoV2 Infection, COVID-19 Pneumonia
    View official trial listing →
  • Completed NCT NCT04972396

    Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

    Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sites Stand-alone
    MASH
    View official trial listing →
  • Status unknown NCT NCT04974814

    Effect of Statin Preloading in STEMI in Improving PCI Outcomes

    Not yet reported Beni-Suef University 99 participants Est. completion 2023-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT04984616

    Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease

    Not yet reported Juan D. Maya 300 participants Est. completion 2024-04-01 4 sites Stand-alone
    Other conditions: Chronic Chagas Disease
    View official trial listing →
  • Not yet recruiting NCT NCT05049603

    A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

    Not yet reported University of Pisa 102 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Graves' Orbitopathy
    View official trial listing →
  • Status unknown NCT NCT05072054

    Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 80 participants Est. completion 2022-08-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05093205

    STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS

    Not yet reported Pfizer 35 participants Est. completion 2022-07-06 1 site Stand-alone
    Other conditions: Healthy Adults
    View official trial listing →
  • Status unknown NCT NCT05103644

    Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

    Not yet reported, Not yet reported Beni-Suef University 60 participants Est. completion 2024-12-30 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05122780

    Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120 participants Est. completion 2025-07 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05131997

    A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

    Not yet reported Addpharma Inc. 290 participants Est. completion 2022-06-08 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT05165251

    Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

    Not yet reported Shanghai Jiao Tong University School of Medicine 480 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Isolated Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT05238012

    Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

    Not yet reported Heart Health Research Center 392 participants Est. completion 2024-04-02 1 site
    Other conditions: Metabolism Disorder, Lipid, Metabolism Disorder, Glucose
    View official trial listing →
  • Completed NCT NCT05250596

    COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)

    Not yet reported Azienda USL Toscana Centro 182 participants Est. completion 2024-05-30 3 sites Stand-alone
    Other conditions: Non ST Segment Elevation Acute Coronary Syndrome
    View official trial listing →
  • Withdrawn NCT NCT05251129

    Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation

    Not yet reported Montefiore Medical Center Est. completion 2030-06 Stand-alone
    Other conditions: Vasculopathy
    View official trial listing →
  • Completed NCT NCT05285085

    Real World Evidence Study of Statin Use in Brazil

    Hospital Israelita Albert Einstein 2133900 participants Est. completion 2021-12-15 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes Mellitus, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT05298475

    Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2024-04-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT05306990

    Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome

    Not yet reported Helwan University 108 participants Est. completion 2021-01-31 1 site
    Other conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05327595

    A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Eli Lilly and Company 80 participants Est. completion 2024-04-22 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT05331053

    MicroRNA Activation of LOX-1 Mechanisms in Endometriosis

    Not yet reported Penn State University 6 participants Est. completion 2024-08-31 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT05334108

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

    Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT05342974

    Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy

    Not yet reported University of Utah 9 participants Est. completion 2025-01-06 1 site Stand-alone
    Other conditions: Abortion Early
    View official trial listing →
  • Active, not recruiting NCT NCT05361421

    Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

    Not yet reported Yonsei University 1200 participants Est. completion 2027-10-15 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05368545

    Influence of Lipid Lowering on Impaired Coronary Flow

    Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05372380

    A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 32 participants Est. completion 2022-06-30 1 site
    Other conditions: Hypertension, Hypercholesterinemia
    View official trial listing →
  • Status unknown NCT NCT05395143

    Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 92 participants Est. completion 2022-07-10 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT05398393

    An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150 participants Est. completion 2023-06-30 1 site
    Other conditions: Hepatitis B, Chronic, Lipid Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05462262

    Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 2900 participants Est. completion 2029-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05464628

    Drug Interaction Study of ASC42 With Atorvastatin

    Not yet reported Gannex Pharma Co., Ltd. 12 participants Est. completion 2022-08-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05479097

    Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage

    Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05483894

    Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial

    Not yet reported Samsung Medical Center 36 participants Est. completion 2025-01-31
    Other conditions: Hepatitis B, Portal Hypertension
    View official trial listing →
  • Completed NCT NCT05488067

    Atorvastatin Therapy on Xanthoma in Alagille Syndrome

    Not yet reported Children's Hospital of Fudan University 15 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Alagille Syndrome, Atorvastatin, Xanthoma
    View official trial listing →
  • Status unknown NCT NCT05504330

    Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients

    Anhui Medical University 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Asymptomatic Intracranial Stenosis, Cognitive Impairment, Cerebrovascular Event
    View official trial listing →
  • Status unknown NCT NCT05507398

    The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

    Not yet reported Tanta University 100 participants Est. completion 2023-09
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT05511766

    Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis

    Not yet reported, Not yet reported Tanta University 150 participants Est. completion 2026-01-25 1 site
    Other conditions: Cirrhosis, Hepatic Encephalopathy, Ascites, Varices, SBP - Spontaneous Bacterial Peritonitis
    View official trial listing →
  • Completed NCT NCT05551624

    Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

    Not yet reported Hospital Civil de Guadalajara 15 participants Est. completion 2020-01-23 1 site Stand-alone
    Other conditions: Primary Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT05555238

    An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia

    Hanmi Pharmaceutical Company Limited 1716 participants Est. completion 2022-01-27 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05559606

    An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

    Boryung Pharmaceutical Co., Ltd 1839 participants Est. completion 2025-07-30 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT05561062

    Atorvastatin in Patients With Ulcerative Colitis

    Not yet reported Tanta University 50 participants Est. completion 2024-11-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT05563389

    Statin Impact on Hepatic Decompensation

    Not yet reported, Not yet reported Tanta University 100 participants Est. completion 2023-02-25 1 site
    Other conditions: Quality of Life, the Incidence of Whole Complications Resultant From Decompensated Liver
    View official trial listing →
  • Status unknown NCT NCT05565976

    Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

    Not yet reported, Not yet reported Jaime Daniel Mondragon 270 participants Est. completion 2025-07-01 1 site Stand-alone
    Cardiovascular diseaseMetabolic syndrome Other conditions: Mild Cognitive Impairment, Dementia, Vascular
    View official trial listing →
  • Completed NCT NCT05567068

    Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

    Not yet reported Tanta University 54 participants Est. completion 2025-06-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT05583643

    Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment

    Not yet reported Misr University for Science and Technology 24 participants Est. completion 2022-06-30 1 site
    Other conditions: Periodontitis
    View official trial listing →
  • Status unknown NCT NCT05585151

    High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2024-10-01 1 site
    Other conditions: Cerebral Atherosclerosis
    View official trial listing →
  • Active, not recruiting NCT NCT05586750

    Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

    Not yet reported Monash University 341 participants Est. completion 2026-09 2 sites Stand-alone
    Other conditions: Dementia, Mixed, Dementia, Vascular, Dementia of Alzheimer Type, Cognitive Decline, White Matter Hyperintensity, Aging, Neuro-Degenerative Disease
    View official trial listing →
  • Not yet recruiting NCT NCT05589454

    Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds

    Not yet reported Sichuan Provincial People's Hospital 344 participants Est. completion 2027-06 5 sites Stand-alone
    Cardiovascular disease Other conditions: Cerebral Microbleeds
    View official trial listing →
  • Status unknown NCT NCT05620615

    Intensive Drug Therapy for Ischemic Stroke

    Shanghai Yueyang Integrated Medicine Hospital 42 participants Est. completion 2023-12-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05624658

    Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS

    Not yet reported Samara Regional Cardiology Dispensary 200 participants Est. completion 2024-05 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05642845

    Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-06-05 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT05675787

    Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

    Not yet reported Peking University People's Hospital 82 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I
    View official trial listing →
  • Completed NCT NCT05679102

    Atorvastatin as an Antihypertensive Agent

    Not yet reported Himayat Ullah 120 participants Est. completion 2023-01-04 1 site
    Other conditions: Atorvastatin Antihypertensive Effect
    View official trial listing →
  • Completed NCT NCT05681273

    Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

    Not yet reported Chipscreen Biosciences, Ltd. 48 participants Est. completion 2023-03-21 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05697185

    Safety and Efficacy of Evolocumab in Ischemic Stroke

    Not yet reported Second Affiliated Hospital of Guangxi Medical University 200 participants Est. completion 2024-12-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05730634

    The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2022-05-06 1 site Stand-alone
    Type 2 diabetes Other conditions: Vascular Inflammation
    View official trial listing →
  • Status unknown NCT NCT05741086

    Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 80 participants Est. completion 2024-08-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05747768

    A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients

    Not yet reported Peking University Third Hospital 60 participants Est. completion 2024-12-31 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05761444

    Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

    Not yet reported Organon and Co 137 participants Est. completion 2024-10-15 7 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05764317

    Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

    Servier Russia 409 participants Est. completion 2024-02-20 1 site
    Other conditions: Arterial Hypertension, HTN
    View official trial listing →
  • Completed NCT NCT05790499

    LDL-c Level Variability and Trained Immunity

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 11 participants Est. completion 2025-04-03 1 site Stand-alone
    Other conditions: Cholesterol Variability, Trained Immunity
    View official trial listing →
  • Status unknown NCT NCT05792293

    Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

    Not yet reported, Not yet reported Ain Shams University 100 participants Est. completion 2023-06 1 site Stand-alone
    Other conditions: Doxorubicin Induced Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT05792540

    Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

    Not yet reported Tanta University 75 participants Est. completion 2024-12-20 1 site
    Other conditions: Depressive Disorder
    View official trial listing →
  • Completed NCT NCT05806723

    Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men

    Not yet reported Hopital La Rabta 104 participants Est. completion 2022-09-15 1 site Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus, Statin Adverse Reaction, Hypogonadism, Male, Adrenal Insufficiency, Vitamin D Deficiency
    View official trial listing →
  • Status unknown NCT NCT05812404

    Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

    Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2023-06-16 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Status unknown NCT NCT05814692

    BIOchemical Urine Analysis of Adherence to Statins and Associated FACTorS in Coronary Artery Disease

    Heinrich-Heine University, Duesseldorf 130 participants Est. completion 2024-09 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT05815680

    A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects

    Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 48 participants Est. completion 2023-10-30 1 site Stand-alone
    Other conditions: Overweight Subjects, Obese Subjects
    View official trial listing →
  • Enrolling by invitation NCT NCT05826912

    Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

    Not yet reported University of California, San Francisco 672 participants Est. completion 2029-08-31 18 sites
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Status unknown NCT NCT05839236

    COVID-19 Vaccination Detoxification in LDL-C

    Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-07-31 1 site Stand-alone
    Cardiovascular disease Other conditions: COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism, COVID-19 Post-Intensive Care Syndrome, COVID-19 Respiratory Infection
    View official trial listing →
  • Completed NCT NCT05845580

    Patient Autonomy and Statin Therapy Adherence

    Not yet reported Lithuanian University of Health Sciences 300 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Drug Adherence
    View official trial listing →
  • Enrolling by invitation NCT NCT05870007

    Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

    Not yet reported Taipei Medical University Shuang Ho Hospital 30 participants Est. completion 2026-12 3 sites
    Chronic kidney disease Other conditions: Autosomal Dominant Polycystic Kidney Disease
    View official trial listing →
  • Completed NCT NCT05877235

    Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

    Not yet reported InCor Heart Institute 60 participants Est. completion 2024-06-23 1 site Stand-alone
    Cardiovascular disease Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT05893849

    Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults

    Peking University Third Hospital 624 participants Est. completion 2024-04 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT05895123

    Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

    Not yet reported Damanhour University 80 participants Est. completion 2023-04-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT05910476

    Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

    Not yet reported Yonsei University 200 participants Est. completion 2026-09-22 1 site
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT05912686

    High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

    Not yet reported Zhongda Hospital 162 participants Est. completion 2026-07-31 1 site
    Cardiovascular disease Other conditions: Mechanical Thrombectomy
    View official trial listing →
  • Status unknown NCT NCT05925140

    LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

    Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites Stand-alone
    Other conditions: COVID-19, Hospitalized COVID-19 Patients
    View official trial listing →
  • Completed NCT NCT05930028

    A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

    Not yet reported Boryung Pharmaceutical Co., Ltd 148 participants Est. completion 2024-09-05 1 site Stand-alone
    Other conditions: Essential Hypertension, Primary Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT05933720

    Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.

    Not yet reported Ryazan State Medical University 120 participants Est. completion 2026-09-01 1 site
    Other conditions: Peripheral Arterial Occlusive Disease
    View official trial listing →
  • Status unknown NCT NCT05946122

    Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index

    Not yet reported Minia University 106 participants Est. completion 2023-12-30 1 site
    Other conditions: Renal Protection
    View official trial listing →
  • Completed NCT NCT05970679

    Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

    Not yet reported Daewon Pharmaceutical Co., Ltd. 252 participants Est. completion 2023-04-13 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT05976893

    Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

    Not yet reported Xiang Xie 620 participants Est. completion 2025-12-31 Stand-alone
    Cardiovascular disease Other conditions: Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor, Cancer
    View official trial listing →
  • Completed NCT NCT05996978

    Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis

    Shanghai Yueyang Integrated Medicine Hospital 42 participants Est. completion 2023-04-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06024096

    Systems Biological Assessment of Statin Effect on Vaccine Responses

    Not yet reported Emory University 63 participants Est. completion 2024-12-16 1 site
    Other conditions: Vaccine Response
    View official trial listing →
  • Status unknown NCT NCT06052020

    Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study

    The First Affiliated Hospital with Nanjing Medical University 50 participants Est. completion 2024-09-30 1 site
    Cardiovascular disease Other conditions: Intracranial Atherosclerotic Stenosis
    View official trial listing →
  • Completed NCT NCT06053983

    Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome

    Not yet reported Rawalpindi Medical College 126 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Mi Q Wave
    View official trial listing →
  • Status unknown NCT NCT06080256

    Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 80 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis
    View official trial listing →
  • Completed NCT NCT06081166

    A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

    Not yet reported NewAmsterdam Pharma 74 participants Est. completion 2024-01-22 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06083337

    Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography

    Not yet reported Hippocration General Hospital 140 participants Est. completion 2025-07-22 1 site Stand-alone
    Cardiovascular disease Other conditions: Atheroscleroses, Coronary, Vascular Inflammation
    View official trial listing →
  • Completed NCT NCT06094244

    Statins in Patients With Spontaneous Intracerebral Hemorrhage

    Not yet reported Pomeranian Medical University Szczecin 153 participants Est. completion 2021-03-17 1 site Stand-alone
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Not yet recruiting NCT NCT06096909

    Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

    Not yet reported China National Center for Cardiovascular Diseases 3684 participants Est. completion 2027-11-01 Stand-alone
    Other conditions: Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06112028

    Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

    Not yet reported Yanbin Li 200 participants Est. completion 2026-11 Stand-alone
    Other conditions: Stent Restenosis
    View official trial listing →
  • Status unknown NCT NCT06134635

    Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

    Xuanwu Hospital, Beijing 80 participants Est. completion 2024-12-01
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06139952

    Ameliorating Contrast Induced Nephropathy After Coronary Angiography

    Not yet reported Ain Shams University 120 participants Est. completion 2024-07-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Nephropathy; Toxic, Drugs
    View official trial listing →
  • Status unknown NCT NCT06140095

    Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

    Not yet reported Region Stockholm 8 participants Est. completion 2025-12 Stand-alone
    Other conditions: Acute Metabolic Effects of Evolocumab and Atorvastatin
    View official trial listing →
  • Active, not recruiting NCT NCT06157099

    Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma

    Not yet reported OHSU Knight Cancer Institute 150 participants Est. completion 2029-09-01 1 site Stand-alone
    Other conditions: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIB Cutaneous Melanoma AJCC v8
    View official trial listing →
  • Completed NCT NCT06191991

    A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

    Not yet reported Aligos Therapeutics 14 participants Est. completion 2023-12-04 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06208384

    Topical Statin Eye Drop in the Management of the Dry Eye

    Not yet reported, Not yet reported Shahid Beheshti University of Medical Sciences 20 participants Est. completion 2025-02-04 1 site Stand-alone
    Other conditions: Dry Eye Disease
    View official trial listing →
  • Status unknown NCT NCT06239714

    A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

    Not yet reported Suzhou Sanegene Bio Inc. 64 participants Est. completion 2025-05-30 Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT06241352

    Statin Addition to Chemotherapy for Advanced Pancreatic Cancer

    Not yet reported Changhai Hospital 42 participants Est. completion 2025-04-30 1 site Stand-alone
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT06262685

    Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 216 participants Est. completion 2025-03-04 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy
    View official trial listing →
  • Status unknown NCT NCT06273215

    Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

    Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT06280976

    Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

    Not yet reported University of Louisville Est. completion 2025-01-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis, Heart Attack
    View official trial listing →
  • Status unknown NCT NCT06286059

    Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI

    Not yet reported, Not yet reported Helwan University 60 participants Est. completion 2025-01-31 1 site
    Cardiovascular disease Other conditions: CA-AKI - Contrast-Associated Acute Kidney Injury, Acute Coronary Syndrome, Adrenergic Receptor Antagonist Adverse Reaction
    View official trial listing →
  • Completed NCT NCT06289504

    A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

    Not yet reported Novo Nordisk A/S 34 participants Est. completion 2024-11-15 1 site Added to GLP-1
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06293742

    ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

    Not yet reported Eccogene 48 participants Est. completion 2024-04-15 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06364124

    Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

    Not yet reported Beijing Luhe Hospital 84 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: STEMI
    View official trial listing →
  • Enrolling by invitation NCT NCT06369571

    Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet

    Not yet reported, Not yet reported Johns Hopkins University 22 participants Est. completion 2027-12 1 site
    Other conditions: Epilepsy, Dyslipidemia
    View official trial listing →
  • Active, not recruiting NCT NCT06372925

    Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

    Not yet reported Novartis Pharmaceuticals 318 participants Est. completion 2027-01-26 19 sites Stand-alone
    Other conditions: Plaque, Atherosclerotic
    View official trial listing →
  • Status unknown NCT NCT06382974

    Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP

    Not yet reported Cairo University 10 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Infection, Bone Loss
    View official trial listing →
  • Completed NCT NCT06403787

    Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment

    Not yet reported, Not yet reported University of Guadalajara 28 participants Est. completion 2024-04-01 1 site
    Other conditions: Human Immunodeficiency Virus
    View official trial listing →
  • Status unknown NCT NCT06422650

    Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 84 participants Est. completion 2024-08-31 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT06469450

    KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts

    Not yet reported Mikko Niemi 15 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Pharmacodynamics
    View official trial listing →
  • Completed NCT NCT06545461

    Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

    Not yet reported Donald Wesson 108 participants Est. completion 2016-10-30 Stand-alone
    Chronic kidney diseaseCardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT06551298

    Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 129 participants Est. completion 2025-08-08 1 site
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT06553157

    Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

    Not yet reported, Not yet reported Minia University 56 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Solid Tumors, Ototoxicity
    View official trial listing →
  • Withdrawn NCT NCT06559072

    Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)

    Not yet reported The George Institute Est. completion 2026-09-01 1 site Stand-alone
    Other conditions: Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Aneurysmal Subarachnoid Hemorrhage, Hemorrhage, Aneurysmal Subarachnoid
    View official trial listing →
  • Completed NCT NCT06567327

    A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

    Not yet reported Pfizer 82 participants Est. completion 2025-04-14 3 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06601517

    A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30 participants Est. completion 2025-04 1 site Stand-alone
    Other conditions: Healthy Adult Subject, Overweight Subject
    View official trial listing →
  • Completed NCT NCT06615284

    A Study of Atorvo+™ in Healthy Adult Participants

    Not yet reported Indication Bioscience LLC 24 participants Est. completion 2025-06-10 1 site Stand-alone
    Other conditions: Coronary Heart Disease, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT06642740

    Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia

    Beijing Ditan Hospital 108 participants Est. completion 2025-06-01 1 site
    Other conditions: Chronic Liver Disease, Thrombopenia
    View official trial listing →
  • Completed NCT NCT06674044

    Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population

    Riphah International University 100 participants Est. completion 2024-08-31 1 site
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT06684366

    Chronic Coronary Syndrome Real Practice and Guidelines

    Assiut University 300 participants Est. completion 2025-10-22 1 site
    Other conditions: Coronary Arterial Disease (CAD)
    View official trial listing →
  • Not yet recruiting NCT NCT06684509

    Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

    Not yet reported, Not yet reported Assiut University 46 participants Est. completion 2029-09 1 site
    Other conditions: Leukemia, Hodgkin Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06686615

    A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sites
    Other conditions: Primary Hypercholesterolemiia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT06696820

    Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

    Not yet reported, Not yet reported Xiang Luo 429 participants Est. completion 2026-06-03 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06699355

    A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)

    Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2023-12-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06723691

    Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

    Not yet reported Fujian Shengdi Pharmaceutical Co., Ltd. 57 participants Est. completion 2025-06-09 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06782243

    Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

    Not yet reported Khyber Medical University Peshawar 190 participants Est. completion 2025-08-25 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06785727

    StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial

    Not yet reported Prof. dr. Nathalie van der Velde 612 participants Est. completion 2029-07-01 Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Not yet recruiting NCT NCT06785974

    Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

    Not yet reported Erasmus Medical Center 140 participants Est. completion 2030-02 1 site Stand-alone
    Other conditions: Atherosclerosis, Melanoma, Immune-related Adverse Event
    View official trial listing →
  • Withdrawn NCT NCT06789432

    Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

    Not yet reported Dr. Md. Alimur Reza Est. completion 2025-12 1 site Stand-alone
    Other conditions: Hyperlipidemia (E.G., Hypercholesterolemia)
    View official trial listing →
  • Not yet recruiting NCT NCT06791031

    PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)

    Not yet reported West China Hospital 212 participants Est. completion 2028-06 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT06796660

    Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients

    Not yet reported Liu Zhanghong 70 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT06841536

    Combined Effects of Statins and Exercise on Training Sensitive Health Markers

    Not yet reported University of the Faroe Islands 120 participants Est. completion 2026-01-30 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Not yet recruiting NCT NCT06856772

    Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

    Not yet reported Tor Biering-Sørensen 42000 participants Est. completion 2028-03-28 1 site Stand-alone
    Cardiovascular disease Other conditions: Drug Effect
    View official trial listing →
  • Completed NCT NCT06866509

    To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients

    Daewoong Pharmaceutical Co. LTD. 3000 participants Est. completion 2024-02-28 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT06871358

    The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients

    Not yet reported Universitas Sebelas Maret 40 participants Est. completion 2024-11-20 1 site
    Other conditions: STEMI (STE-ACS), Primary PCI for STEMI
    View official trial listing →
  • Active, not recruiting NCT NCT06924684

    High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI

    Not yet reported Sheikh Zayed Federal Postgraduate Medical Institute 66 participants Est. completion 2025-07-02 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06948747

    A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

    Not yet reported AstraZeneca 49 participants Est. completion 2025-10-03 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT06974084

    A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID

    Not yet reported, Not yet reported HealthBio, Inc. 252 participants Est. completion 2027-05 1 site
    Other conditions: Long COVID
    View official trial listing →
  • Active, not recruiting NCT NCT06976866

    Effect of Topical Application of Atorvastatin Gel Versus Hyaluronic Acid on Immediate Loading Dental Implant in Posterior Maxilla

    Not yet reported Amira attia 21 participants Est. completion 2025-05-14 1 site Stand-alone
    Other conditions: In Recent Years, There Has Been a Rise in the Use of Immediate Loading Protocols, Dental Implant Stability
    View official trial listing →
  • Completed NCT NCT07008794

    Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs

    Assiut University 200 participants Est. completion 2023-03-31 1 site
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Active, not recruiting NCT NCT07042165

    Treatment of Bile Acid Diarrhoea With Atorvastatin

    Not yet reported Asger Lund, MD 20 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Bile Acid Diarrhea, Bile Acid Malabsorption
    View official trial listing →
  • Not yet recruiting NCT NCT07087379

    Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)

    Not yet reported Pan Xiangbin 500 participants Est. completion 2028-01-01 Stand-alone
    Other conditions: Aortic Stenosis, Cerebral Ischaemic Injury
    View official trial listing →
  • Not yet recruiting NCT NCT07088523

    Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study

    Not yet reported Guangzhou University of Traditional Chinese Medicine 4205 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Diabete Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT07121088

    Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

    Not yet reported Guangzhou University of Traditional Chinese Medicine 3666 participants Est. completion 2027-12-31
    Other conditions: Ischemic Cerebral Infarction, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT07128212

    Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1

    Not yet reported Suzhou Municipal Hospital of Anhui Province 401 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Ischemic White Matter Lesions (WMIL), Cerebral Small Vessel Disease, Vascular Cell Adhesion Molecule-1, VCAM-1
    View official trial listing →
  • Completed NCT NCT07148037

    Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population

    Riphah International University 150 participants Est. completion 2025-07-31 1 site
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Not yet recruiting NCT NCT07180745

    Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

    Not yet reported Badr University 400 participants Est. completion 2026-03-01 1 site
    MASLDMASH
    View official trial listing →
  • Not yet recruiting NCT NCT07197463

    The Therapeutic Effect of Phase I Cardiac Rehabilitation on Elderly Patients With CHD Complicated by Sarcopenia

    Not yet reported Qilu Hospital of Shandong University 100 participants Est. completion 2026-11-10 Stand-alone
    Other conditions: Coronary Disease, Sarcopenia
    View official trial listing →
  • Completed NCT NCT07235189

    A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-01-28 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT07268625

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-02-24 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT07278830

    A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 214 participants Est. completion 2024-06-07 1 site Stand-alone
    Other conditions: Hypercholesterolemia and Mixed Dyslipidemia
    View official trial listing →
  • Not yet recruiting NCT NCT07290699

    Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

    Not yet reported Second Affiliated Hospital of Nanchang University 2442 participants Est. completion 2028-08-30 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07301372

    Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 132 participants Est. completion 2026-06-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT07362030

    Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 32 participants Est. completion 2026-03-30 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT07378228

    Weak Pulse at Yang and Wiry Pulse at Yin Theory

    Not yet reported Xikun Li 70 participants Est. completion 2024-06-01 1 site Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina Pectoris
    View official trial listing →
  • Not yet recruiting NCT NCT07378293

    Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

    Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 2 sites Stand-alone
    Other conditions: Diabete Mellitus, Lipid Profile
    View official trial listing →
  • Not yet recruiting NCT NCT07389304

    [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]

    Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 1 site Stand-alone
    Other conditions: Lipid Profile,Blood Pressure
    View official trial listing →
  • Not yet recruiting NCT NCT07462715

    Statins Against Bushfire Smoke

    Not yet reported Menzies Institute for Medical Research 100 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Healthy Adults
    View official trial listing →
  • Not yet recruiting NCT NCT07474649

    A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

    Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-alone
    Other conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07489183

    A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

    Dong Wha Pharmaceutical Co. Ltd. 641 participants Est. completion 2023-09-07 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07497776

    Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

    Not yet reported National Institute of Kidney Disease and Urology (NIKDU) 100 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Not yet recruiting NCT NCT07502001

    Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 42 participants Est. completion 2027-06-02 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07508254

    Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

    Not yet reported Punjab Institute of Cardology 120 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes (ACS), Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07511686

    Metabolic and Mitochondrial Changes in Statin-Induced Myopathy

    Riga Stradins University 38 participants Est. completion 2024-10-09 1 site
    Other conditions: Statin Adverse Reaction, Statin-induced Myopathy
    View official trial listing →
  • Completed NCT NCT07530289

    A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2026-06-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT07534592

    A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

    Not yet reported AstraZeneca 48 participants Est. completion 2026-10-01 2 sites Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07549932

    Adjunctive Role of Statin Therapy on Airway Inflammation and Clinical Consequences of Chronic Obstructive Pulmonary Disease

    Not yet reported Mohamed Salah El-Sayed 80 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Statin, Airway Disease, Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Completed NCT NCT07578857

    Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia

    Not yet reported Riphah International University 60 participants Est. completion 2023-10-25 1 site
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Not yet recruiting NCT NCT07586540

    Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque

    Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 280 participants Est. completion 2030-09 14 sites Stand-alone
    Other conditions: Carotid Stenosis
    View official trial listing →
  • Not yet recruiting NCT NCT07605130

    Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial

    Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-alone
    Other conditions: Intracranial Arteriosclerosis, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT07608705

    A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2026-08-24 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT07624604

    Evaluation of the Therapeutic Efficacy of Auricular Pellets Combined With Atorvastatin 20mg in Patients With Dyslipidemia and Phlegm-Dampness Syndrome

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 80 participants Est. completion 2026-06-10 1 site Stand-alone
    Other conditions: Phlegm-Dampness Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07626840

    Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31
    Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Not yet recruiting NCT NCT07630363

    PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

    Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40 participants Est. completion 2030-04-01 1 site Stand-alone
    Other conditions: Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With Immunotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT07634341

    Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.

    Not yet reported Fayoum University 80 participants Est. completion 2027-12 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Not yet recruiting NCT NCT07662525

    Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

    Not yet reported Peking University People's Hospital 50 participants Est. completion 2028-12-30 1 site Stand-alone
    Other conditions: Immune Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT07668076

    The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

    Not yet reported Damanhour University 44 participants Est. completion 2024-10-20 1 site Stand-alone
    Other conditions: Breast Cancer, Doxorubicin Induced Cardiomyopathy
    View official trial listing →
  • Not yet recruiting NCT NCT07685054

    To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.

    Boryung Pharmaceutical Co., Ltd 12700 participants Est. completion 2029-08-15
    Other conditions: Essential Hypertension, Primary Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07699003

    Endovascular Treatment of Chronic Intracranial Artery Occlusion

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 382 participants Est. completion 2030-08-01
    Other conditions: Chronic Intracranial Artery Occlusion
    View official trial listing →
  • Completed NCT NCT07702669

    Modified Huanglian Wendan Decoction for Metabolic Syndrome

    Not yet reported First Affiliated Hospital of Heilongjiang Chinese Medicine University 180 participants Est. completion 2025-08-31 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT07712367

    Atorvastatin Plus Escitalopram for Depression With Dyslipidemia

    Hengshui City Seventh People's Hospital 60 participants Est. completion 2026-05-27 1 site
    Other conditions: Depressive Episode, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT07717788

    Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

    Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Osteoporosis, Postmenopausal, Statin Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07762105

    Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease

    Not yet reported Banu Aji Dibyasakti 64 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Thyroid Eye Disease, Graves Ophthalmopathy, Graves Orbitopathy
    View official trial listing →
  • Not yet recruiting NCT NCT07784608

    A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers

    Not yet reported Huons Co., Ltd. 28 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Drug-drug Interactions
    View official trial listing →
  • Not yet recruiting NCT NCT07799779

    Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome

    Not yet reported Seoul National University Bundang Hospital 294 participants Est. completion 2029-09 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes (ACS)
    View official trial listing →
  • Not yet recruiting NCT NCT07815704

    Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2031-08 1 site Stand-alone
    Other conditions: Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer, High Grade Serous Adenocarcinoma of Ovary
    View official trial listing →
  • Not yet recruiting NCT NCT07819643

    RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling

    Not yet reported Keqiang Zhao 120 participants Est. completion 2029-12-01 Stand-alone
    Other conditions: Atherosclerosis Cerebral, Carotid Plaque, Vulnerable Plaque, Carotid Stenosis
    View official trial listing →
  • Not yet recruiting NCT NCT07840950

    Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study

    Not yet reported Xiangya Hospital of Central South University 200 participants Est. completion 2029-01-31 Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Plaques, Atherosclerosis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Atorvastatin Calcium Trihydrate, Atorvastatin calcium, Amlodipine and Atorvastatin, Atorvastatin, Atorvastatin Calcium Tablets, Atorvastatin 20 mg

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.